<?xml version="1.0" encoding="UTF-8" standalone="no"?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0"><channel><title>Biopatologia</title><description></description><managingEditor>noreply@blogger.com (Biopatologia)</managingEditor><pubDate>Fri, 8 May 2026 16:55:11 -0300</pubDate><generator>Blogger http://www.blogger.com</generator><openSearch:totalResults xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">85</openSearch:totalResults><openSearch:startIndex xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">1</openSearch:startIndex><openSearch:itemsPerPage xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">25</openSearch:itemsPerPage><link>http://biompato.blogspot.com/</link><language>en-us</language><itunes:explicit>no</itunes:explicit><itunes:subtitle/><itunes:owner><itunes:email>noreply@blogger.com</itunes:email></itunes:owner><item><title>MICOSE NAS PRAIAS</title><link>http://biompato.blogspot.com/2011/05/micose-das-praias.html</link><category>dicas</category><category>micose</category><category>praia</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Thu, 12 May 2011 01:05:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-2210156864296227498</guid><description>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh7wPgMy29kVHIuohKgOawdKKfmEcUA3hdFu3iVUqB7kdK2izsj1bTpIAkDIqyvWuL8o54Kdmc9TClrAQS_jVBuV5j3HNKfYCGVWEIuLY9nJx6MJxY6WTPU4gqTcD4ESSJhv6vKxJNosZrJ/s1600/praia.JPG"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 320px; DISPLAY: block; HEIGHT: 241px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5605679576858729586" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh7wPgMy29kVHIuohKgOawdKKfmEcUA3hdFu3iVUqB7kdK2izsj1bTpIAkDIqyvWuL8o54Kdmc9TClrAQS_jVBuV5j3HNKfYCGVWEIuLY9nJx6MJxY6WTPU4gqTcD4ESSJhv6vKxJNosZrJ/s320/praia.JPG" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;span style="WHITE-SPACE: pre" class="Apple-tab-span"&gt;&lt;/span&gt;&lt;span class="Apple-style-span"&gt;&lt;b&gt;As micoses do tipo superficial são aquelas em que os fungos ficam na camada externa da pele, ao redor de pêlos ou nas unhas, alimentando-se de queratina (proteína). Já nas micoses profundas, os fungos disseminam-se através da circulação sanguínea e linfática. Podem infectar a pele e órgãos internos, como pulmões, intestinos, ossos ou sistema nervoso.&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span class="Apple-style-span"&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span class="Apple-style-span"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span class="Apple-style-span"&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;b&gt;&lt;span style="WHITE-SPACE: pre" class="Apple-tab-span"&gt;&lt;/span&gt;Entre as micoses mais comuns, destacam-se as que originam lesões avermelhadas em virilhas e genitais, que costumam coçar muito; as que acometem as regiões entre os dedos dos pés (popularmente chamada de pé-de-atleta); a pitiríase versicolor, que aparece frequentemente nas costas, dando lesões brancas, róseas ou acastanhadas, e que é conhecida popularmente como pano branco. Além destas, a micose de unhas tira o sono de muita gente, por deixar um aspecto inestético nas unhas acometidas, completa.&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span class="Apple-style-span"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;span class="Apple-style-span"&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;b&gt;&lt;span style="WHITE-SPACE: pre" class="Apple-tab-span"&gt;&lt;/span&gt;A boa notícia é que todas estas micoses são usualmente de fácil tratamento, sendo usados remédios que destruam o fungo, tópicos (cremes, soluções, esmaltes) ou sistêmicos (comprimidos ou cápsulas) em alguns casos. A duração do tratamento é bem variável, de poucas semanas até alguns anos, dependendo do tipo de micose, da extensão da doença, da resistência do fungo à medicação e do estado de defesa do paciente&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;b&gt;&lt;span class="Apple-style-span"  style="color:#ff0000;"&gt;Dicas para evitar micose durante o verão&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;ul&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Não divida toalhas;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Evite tomar banho em chuveiros públicos;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Após o banho seque bem as regiões mais úmidas, principalmente a região da virilha e também os pés;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Só use alicates, tesouras e lixas se estiverem bem esterilizados;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Faça as unhas pelo menos três dias antes de entrar em contato com areia, pois unhas sem cutículas e pés lixados são mais fáceis de contrair fungos e bactérias;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Se estiver passando uma temporada na praia, evite fazer as unhas nesse período, mantenha apenas a cutícula hidratada e se quiser troque a cor do esmalte.&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Evite ficar lixando os pés, isso acaba com a proteção que a sola oferece;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Para deixar os pés macios e hidratados use esfoliantes e cremes para hidratas à noite.&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Não ande descalço em pisos públicos ou molhados;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Dê preferência as meias de algodão;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Evite o uso de sapatos totalmente fechados por tempo prolongado;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Não partilhe luvas, meias ou botas, assim como outras roupas e calçados;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;b&gt;Se você notar que está com alguma área do corpo que apresenta vermelhidão ou coceira, procure um dermatologista, não se automedique, só um especialista poderá dizer qual o tratamento mais eficaz para você.&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span style="LINE-HEIGHT: normal;font-family:'Times New Roman';" class="Apple-style-span" &gt;&lt;span style="PADDING-BOTTOM: 0px; LIST-STYLE-TYPE: none; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; TEXT-DECORATION: none; PADDING-TOP: 0px"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: right"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span style="LINE-HEIGHT: 18px" class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;span class="Apple-style-span"&gt;&lt;b&gt;&lt;i&gt;Posted by: Pedro Antonione T. Arraes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh7wPgMy29kVHIuohKgOawdKKfmEcUA3hdFu3iVUqB7kdK2izsj1bTpIAkDIqyvWuL8o54Kdmc9TClrAQS_jVBuV5j3HNKfYCGVWEIuLY9nJx6MJxY6WTPU4gqTcD4ESSJhv6vKxJNosZrJ/s72-c/praia.JPG" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>II Encontro Caririense de Biomedicina</title><link>http://biompato.blogspot.com/2010/10/ii-encontro-caririense-de-biomedicina.html</link><category>biomedicina</category><category>caririense</category><category>congresso</category><category>Encontro</category><category>juazeiro do norte</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Wed, 20 Oct 2010 03:05:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-2568860749757831220</guid><description>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_GJ57EFMVa6SCJ9a0p5yRC1Jd7PXnsXNROM-f6r8ltV7YD9Wd4wxC8DDWKiTVoFZlyYQFFCUTlycW8oT8YhMeOpVjxianLYt6K9hbFH1s7ZToigfdYY66gYqn-ou5jekF49FawUrLTth-/s1600/II+Encotro+Biomedicina+-+Cartaz.jpg"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 372px; height: 526px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_GJ57EFMVa6SCJ9a0p5yRC1Jd7PXnsXNROM-f6r8ltV7YD9Wd4wxC8DDWKiTVoFZlyYQFFCUTlycW8oT8YhMeOpVjxianLYt6K9hbFH1s7ZToigfdYY66gYqn-ou5jekF49FawUrLTth-/s320/II+Encotro+Biomedicina+-+Cartaz.jpg" alt="" id="BLOGGER_PHOTO_ID_5530005921522859938" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold;font-size:85%;" &gt;Maiores Informações: caoswaldocruz.blogspot.com&lt;/span&gt;&lt;span style="font-size:85%;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="text-align: right;"&gt;&lt;span style="font-style: italic; font-weight: bold;font-size:85%;" &gt;Posted by: Pedro Antonione&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;</description><enclosure length="0" url="http://caoswaldocruz.blogspot.com"/><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_GJ57EFMVa6SCJ9a0p5yRC1Jd7PXnsXNROM-f6r8ltV7YD9Wd4wxC8DDWKiTVoFZlyYQFFCUTlycW8oT8YhMeOpVjxianLYt6K9hbFH1s7ZToigfdYY66gYqn-ou5jekF49FawUrLTth-/s72-c/II+Encotro+Biomedicina+-+Cartaz.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><itunes:explicit/><itunes:subtitle>Maiores Informações: caoswaldocruz.blogspot.com Posted by: Pedro Antonione</itunes:subtitle><itunes:author>noreply@blogger.com (Biopatologia)</itunes:author><itunes:summary>Maiores Informações: caoswaldocruz.blogspot.com Posted by: Pedro Antonione</itunes:summary><itunes:keywords>biomedicina, caririense, congresso, Encontro, juazeiro do norte</itunes:keywords></item><item><title>SÍNDROME DE GUILLAIN-BARRÉ</title><link>http://biompato.blogspot.com/2010/09/sindrome-de-guillain-barre.html</link><category>Guillain-Barré</category><category>síndrome</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Wed, 15 Sep 2010 01:17:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-2585181261571411948</guid><description>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhP-fPG8FUJ0N7cHQI6ERsbUltw7mhdEuI_KlVovbdcLWwMR6nhWAYUFcUisBv8Ej2R9Tu3CDNz4PTrrP85v-oySCCvn-B4_D4NmTo20UUJg69IB5ziFqrpkWUAL1mKZUbEHRe0HRhA1W3s/s1600/sindrome-guillain-barre.jpg"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 320px; height: 213px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhP-fPG8FUJ0N7cHQI6ERsbUltw7mhdEuI_KlVovbdcLWwMR6nhWAYUFcUisBv8Ej2R9Tu3CDNz4PTrrP85v-oySCCvn-B4_D4NmTo20UUJg69IB5ziFqrpkWUAL1mKZUbEHRe0HRhA1W3s/s320/sindrome-guillain-barre.jpg" alt="" id="BLOGGER_PHOTO_ID_5516992036649934482" border="0" /&gt;&lt;/a&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT-BR&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable  {mso-style-name:"Tabela normal";  mso-tstyle-rowband-size:0;  mso-tstyle-colband-size:0;  mso-style-noshow:yes;  mso-style-priority:99;  mso-style-qformat:yes;  mso-style-parent:"";  mso-padding-alt:0cm 5.4pt 0cm 5.4pt;  mso-para-margin-top:0cm;  mso-para-margin-right:0cm;  mso-para-margin-bottom:10.0pt;  mso-para-margin-left:0cm;  line-height:115%;  mso-pagination:widow-orphan;  font-size:11.0pt;  font-family:"Calibri","sans-serif";  mso-ascii-font-family:Calibri;  mso-ascii-theme-font:minor-latin;  mso-fareast-font-family:"Times New Roman";  mso-fareast-theme-font:minor-fareast;  mso-hansi-font-family:Calibri;  mso-hansi-theme-font:minor-latin;  mso-bidi-font-family:"Times New Roman";  mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;p class="MsoNormal" style="text-align: justify; color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;Conceito&lt;/span&gt;&lt;/b&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;: é uma doença do sistema nervoso periférico de risco a vida.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;Etiologia&lt;/span&gt;&lt;/b&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;: resposta inflamatória e mecanismos imunes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;Patogênese&lt;/span&gt;&lt;/b&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;: Uma resposta imune mediada por células-T sobrevém, acompanhada de desmielinização segmentar induzida por macrófagos. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;Alterações morfológicas macroscópicas&lt;/span&gt;&lt;/b&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;: dismielinização segmentar &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;Alterações morfológicas microscópicas&lt;/span&gt;&lt;/b&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;: infiltração perivenular e endoneural por linfócitos T, macrófagos e poucos plasmócitos.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;Alterações funcionais&lt;/span&gt;&lt;/b&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;"  &gt;: O quadro clínico é dominado pela paralisia ascendente. Os reflexos tendíneos profundos desaparecem precocemente. A condução nervosa é diminuída, há elevação da proteína do LCR, há pouca ou nenhuma pleiocitose.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;color:black;"   &gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;DEGENERAÇÃO –&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; ausente; &lt;/span&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;NECROSE/APOPTOSE –&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; ausente; &lt;/span&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;PIGMENTAÇÃO – &lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;ausente; &lt;/span&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;CALCIFICAÇÃO – &lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;ausente; &lt;/span&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;INFLAMAÇÃO –&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; fenômeno dominante; &lt;/span&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;DISTÚRBIO HEMODINÂMICO – &lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;presente como fator secundário; &lt;/span&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;REPARO – &lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;ausente; &lt;/span&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;DISTÚRBIOS DO CRESCIMENTO – &lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;presente como fator secundário;&lt;/span&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt; NEOPLASIA –&lt;/span&gt; ausente.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;br /&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="text-align: right;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:11pt;color:black;"   &gt;&lt;span style="font-style: italic; font-weight: bold;"&gt;Posted by: Pedro Antonione&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhP-fPG8FUJ0N7cHQI6ERsbUltw7mhdEuI_KlVovbdcLWwMR6nhWAYUFcUisBv8Ej2R9Tu3CDNz4PTrrP85v-oySCCvn-B4_D4NmTo20UUJg69IB5ziFqrpkWUAL1mKZUbEHRe0HRhA1W3s/s72-c/sindrome-guillain-barre.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>OLHA A FOGUEIRA!</title><link>http://biompato.blogspot.com/2010/06/olha-fogueira.html</link><category>crianças</category><category>festa juninas</category><category>fogos de artificios</category><category>fogueira</category><category>queimaduras</category><category>são joão</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Wed, 23 Jun 2010 08:11:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-889248534355009530</guid><description>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjjYEKDHy7VTs65_PIX_tMzhhB68Cz1A4fZ8kNHZXAtFF3gLBABUBXbewuPF9ViTstm2OprOMLEsZFHrFGb8uQ7hmZ4ofcWFVk87r9Av1cEtosV_KR0KnRgGlchDh9XIFvFma3e7IGdt2Vo/s1600/junina.jpg"&gt;&lt;img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 283px; height: 320px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjjYEKDHy7VTs65_PIX_tMzhhB68Cz1A4fZ8kNHZXAtFF3gLBABUBXbewuPF9ViTstm2OprOMLEsZFHrFGb8uQ7hmZ4ofcWFVk87r9Av1cEtosV_KR0KnRgGlchDh9XIFvFma3e7IGdt2Vo/s320/junina.jpg" alt="" id="BLOGGER_PHOTO_ID_5485927089152790946" border="0" /&gt;&lt;/a&gt;
&lt;br /&gt;&lt;span style="font-size:85%;"&gt;
&lt;br /&gt;&lt;/span&gt;&lt;div style="text-align: justify;"&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 12"&gt;&lt;meta name="Originator" content="Microsoft Word 12"&gt;&lt;link rel="File-List" href="file:///C:%5CDOCUME%7E1%5CGeral%5CCONFIG%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml"&gt;&lt;link rel="themeData" href="file:///C:%5CDOCUME%7E1%5CGeral%5CCONFIG%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx"&gt;&lt;link rel="colorSchemeMapping" href="file:///C:%5CDOCUME%7E1%5CGeral%5CCONFIG%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT-BR&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="--"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0cm; 	margin-right:0cm; 	margin-bottom:10.0pt; 	margin-left:0cm; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi; 	mso-fareast-language:EN-US;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi; 	mso-fareast-language:EN-US;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:612.0pt 792.0pt; 	margin:70.85pt 3.0cm 70.85pt 3.0cm; 	mso-header-margin:36.0pt; 	mso-footer-margin:36.0pt; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Tabela normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin-top:0cm; 	mso-para-margin-right:0cm; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0cm; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-fareast-language:EN-US;} &lt;/style&gt; &lt;![endif]--&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:130%;"  &gt;&lt;span style="color: rgb(102, 0, 0);"&gt;Nesta época do ano, as pessoas e habitantes tradicionais no interior do país possuem o típico costume de acender fogueiras e soltar fogos de artifícios e, de acordo com a Superintendência de Proteção e Defesa do Consumidor (PROCON), esta atividade aumenta em 50% a incidência de pacientes com queimaduras nos hospitais de todo o Brasil. A tradição junina de acender fogueira é um atrativo particular da Festa de São João. É preciso estar consciente dos riscos que são inerentes á tradição da fogueira junina. Não monte fogueiras muito altas, elas podem desabar durante a queima provocando graves acidentes; nem próximo às linhas de energia elétrica, às árvores, a postos de combustíveis e a locais de concentração de público, como pontos de ônibus, por exemplo; não jogue qualquer produto inflamável para acender a fogueira, pois esse é um tipo de queima não controlada. Não permita que crianças soltem fogos dentro da fogueira. Crianças devem utilizar somente produtos indicados para sua idade e sempre na presença e supervisão de um adulto; acidentes graves podem acontecer com crianças ou adultos que transportam e utilizam fogos de artifícios de forma irregular; nunca transporte estes artefatos nos bolsos, pois, se eles se inflamarem, você certamente será atingido; observe a data de validade dos fogos de artifício, não compre fogos com a data de validade vencida.
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="text-align: right;"&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:130%;"  &gt;&lt;span style="color: rgb(102, 0, 0);"&gt;postado por:&lt;span style="font-weight: bold;"&gt;Alexsandra Souza&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:130%;"&gt;
&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:85%;"  &gt;&lt;span style="color: rgb(102, 0, 0);"&gt;
&lt;br /&gt;
&lt;br /&gt;&lt;/span&gt; &lt;!--[if !supportLineBreakNewLine]--&gt;  &lt;!--[endif]--&gt;&lt;/span&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjjYEKDHy7VTs65_PIX_tMzhhB68Cz1A4fZ8kNHZXAtFF3gLBABUBXbewuPF9ViTstm2OprOMLEsZFHrFGb8uQ7hmZ4ofcWFVk87r9Av1cEtosV_KR0KnRgGlchDh9XIFvFma3e7IGdt2Vo/s72-c/junina.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Neoplasia:auto-suficiência nos sinais de crescimento e sua semelhança com a realidade social</title><link>http://biompato.blogspot.com/2010/06/neoplasiaauto-suficiencia-nos-sinais-de.html</link><category>auto-suficiência</category><category>cirança</category><category>CRESCIMENTO</category><category>drogas</category><category>neoplasia</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Fri, 11 Jun 2010 16:29:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-6385330294467787630</guid><description>&lt;span style="color:#000000;"&gt;&lt;strong&gt;Conceito&lt;/strong&gt; &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;span style="color:#000000;"&gt;Quando uma célula vai sofrer multiplicação, ocorre a ligação de um fator de crescimento a um receptor específico na membrana celular, que resulta em transdução de sinal para o núcleo e indução e ativação da transcrição do DNA.Em neoplasias, células cancerosas adquirem auto-suficiência no crescimento obtendo a capacidade de sintetizar fatores de crescimento aos quais elas respondem, ou ainda estimulam a superprodução de um fator de crescimento ao seu redor.&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiAdwC8_l_cH8NB_5ouUmeI6Rop-mml62YDa8PtirLzZZhvXpgKyg0tlXWbefD-CByCx5LJ7LmlbCqXzJfE4p71VZB7NTkjHAA6KMxEiSmH_qjsxxQp0DWgFcGsmOTvPd_Juz6LnWUF7439/s1600/celulas.png"&gt;&lt;img style="WIDTH: 200px; HEIGHT: 145px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5481601786126919410" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiAdwC8_l_cH8NB_5ouUmeI6Rop-mml62YDa8PtirLzZZhvXpgKyg0tlXWbefD-CByCx5LJ7LmlbCqXzJfE4p71VZB7NTkjHAA6KMxEiSmH_qjsxxQp0DWgFcGsmOTvPd_Juz6LnWUF7439/s200/celulas.png" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;span style="color:#000000;"&gt;&lt;span style="font-size:78%;"&gt;Figura 01 Célula Neoplásica em reprodução devido a sua capacidade de sintetizar fatores de crescimento.&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;A condição no cotidiano&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;span style="color:#000000;"&gt;Os barões do tráfico de drogas nas favelas do Rio de janeiro seriam as células cancerosas que adquirem auto-suficiência no crescimento obtendo capacidade através de bocas de fumo e das próprias crianças marginalizadas que vendem a droga no centro da cidade, escolas, faculdades, etc. As bocas de fumo e as crianças seriam o fatores de crescimento os quais os chefes do tráfico de drogas utilizam para estimular o aumento das vendas, consumo lucro e compra de armas para embate com a polícia. &lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiAUXHPbJmVm8Kzei8NtXAjHm6m9VyR5doTYiMEJDZ0qIyIdKyyt_-57I91MXfbX81rBV1EbSzeWqCh2PZavOD1JDUqTPgtqitDQS4Cby5m5pEFGOMvTMUFQl2ZMvfzL96rzjlp1GhP967m/s1600/social.jpg"&gt;&lt;img style="WIDTH: 182px; HEIGHT: 200px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5481602067238533698" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiAUXHPbJmVm8Kzei8NtXAjHm6m9VyR5doTYiMEJDZ0qIyIdKyyt_-57I91MXfbX81rBV1EbSzeWqCh2PZavOD1JDUqTPgtqitDQS4Cby5m5pEFGOMvTMUFQl2ZMvfzL96rzjlp1GhP967m/s200/social.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;span style="font-size:78%;"&gt;&lt;span style="color:#000000;"&gt;Figura 02. As crianças (fatores de crescimento ) que trabalham para o tráfico de drogas&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="right"&gt;&lt;em&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Posted by: Pedro Antonione&lt;/span&gt;&lt;/strong&gt;&lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiAdwC8_l_cH8NB_5ouUmeI6Rop-mml62YDa8PtirLzZZhvXpgKyg0tlXWbefD-CByCx5LJ7LmlbCqXzJfE4p71VZB7NTkjHAA6KMxEiSmH_qjsxxQp0DWgFcGsmOTvPd_Juz6LnWUF7439/s72-c/celulas.png" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>DISTURBIOS HEMODINÂMICOS- Edema por Obstrução Linfática</title><link>http://biompato.blogspot.com/2010/06/disturbios-hemodinamicos-edema-por.html</link><category>bloqueio</category><category>fluxo</category><category>inchaço</category><category>obstrução linfatica</category><category>transporte coletivo</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Fri, 11 Jun 2010 09:02:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-1249168388922413867</guid><description>
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="font-size:85%;"&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiNmhvMrL5yo64bT-Hi-m1fkePGSRl83QLnA2fejSNVSaBOayHoXA0Ec9Tq3BZIqiKGwjjrcnL7PZ_dFKbO9hGwDNHYmwxxbVrIysr0l_Vm9xy2AL0bxxo6DkCgeygxJdW_1zX1LktCksok/s1600/linfa.jpg"&gt;&lt;img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 227px; height: 259px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiNmhvMrL5yo64bT-Hi-m1fkePGSRl83QLnA2fejSNVSaBOayHoXA0Ec9Tq3BZIqiKGwjjrcnL7PZ_dFKbO9hGwDNHYmwxxbVrIysr0l_Vm9xy2AL0bxxo6DkCgeygxJdW_1zX1LktCksok/s320/linfa.jpg" alt="" id="BLOGGER_PHOTO_ID_5481489687995381266" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="PowerPoint.Slide"&gt;&lt;meta name="Generator" content="Microsoft PowerPoint 12"&gt;&lt;span style="color: rgb(255, 102, 0);font-size:100%;" &gt;A obstrução linfática é um bloqueio dos vasos linfáticos. O linfedema é um&lt;/span&gt;&lt;span style="color: rgb(255, 102, 0);font-size:100%;" &gt; inchaço que pode ocorrer por causa de uma obstrução linfática. &lt;/span&gt;&lt;span style="color: rgb(255, 102, 0);font-size:100%;" &gt;Os vasos linfáticos contêm veias que funcionam como válvulas, as quais possibilitam um fluxo unidirecional. Os vasos linfáticos restituem os fluídos coletados dos tecidos para a corrente sangüínea. Quando os vasos linfáticos ficam obstruídos, os fluídos permanecem nos &lt;/span&gt;&lt;span style="color: rgb(255, 102, 0);font-size:100%;" &gt;tecidos, &lt;/span&gt;&lt;span style="color: rgb(255, 102, 0);font-size:100%;" &gt;causando o inchaço (edema). A linfa desempenha um papel importante no sist&lt;/span&gt;&lt;span style="color: rgb(255, 102, 0);font-size:100%;" &gt;em&lt;/span&gt;&lt;span style="color: rgb(255, 102, 0);font-size:100%;" &gt;a imune, uma vez que combate infecções e evita a invasão de corpos estranhos.&lt;/span&gt;&lt;/div&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; direction: ltr; unicode-bidi: embed; vertical-align: baseline; text-align: justify; font-weight: bold;"&gt;&lt;span style=";font-family:Arial;font-size:180%;color:black;"   &gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; direction: ltr; unicode-bidi: embed; vertical-align: baseline; text-align: justify; font-weight: bold;"&gt;&lt;span style=";font-family:Arial;font-size:180%;color:black;"   &gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; direction: ltr; unicode-bidi: embed; vertical-align: baseline; text-align: justify; font-weight: bold;"&gt;&lt;span style=";font-family:Arial;font-size:180%;color:black;"   &gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; direction: ltr; unicode-bidi: embed; vertical-align: baseline; text-align: center; font-weight: bold;"&gt;&lt;span style=";font-family:Arial;font-size:180%;color:black;"   &gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; direction: ltr; unicode-bidi: embed; vertical-align: baseline; text-align: center; font-weight: bold;"&gt;&lt;span style=";font-family:Arial;font-size:180%;color:black;"   &gt;Veja uma situação em nosso cotidiano que mostra como isso acontec&lt;/span&gt;&lt;span style=";font-family:Arial;font-size:180%;color:black;"   &gt;e dentro de Você.&lt;/span&gt;&lt;/p&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="PowerPoint.Slide"&gt;&lt;meta name="Generator" content="Microsoft PowerPoint 12"&gt;  &lt;p style="margin-top: 0pt; margin-bottom: 0pt; direction: ltr; unicode-bidi: embed; vertical-align: baseline; text-align: justify; font-weight: bold;"&gt;
&lt;br /&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; direction: ltr; unicode-bidi: embed; vertical-align: baseline; text-align: justify; font-weight: bold;"&gt;
&lt;br /&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; direction: ltr; unicode-bidi: embed;"&gt;&lt;span style="color: rgb(0, 0, 102);font-family:Calibri;font-size:100%;"  &gt;     &lt;/span&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgx_kkkljslsUZKx-ZBP8JbD3uzk5ZJwdB9C__xjn3VuXimh1Pn3KuOaL9zzsLfpuniCSmw46oiJAvkcBtvaTTLGfueo7_r4oTLCE58rtuPQT3Hko6LXfvsNceSkYXa3CSd__bW91Gs2dqv/s1600/Imagem1.jpg"&gt;&lt;img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 285px; height: 188px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgx_kkkljslsUZKx-ZBP8JbD3uzk5ZJwdB9C__xjn3VuXimh1Pn3KuOaL9zzsLfpuniCSmw46oiJAvkcBtvaTTLGfueo7_r4oTLCE58rtuPQT3Hko6LXfvsNceSkYXa3CSd__bW91Gs2dqv/s200/Imagem1.jpg" alt="" id="BLOGGER_PHOTO_ID_5481499246943187954" border="0" /&gt;&lt;span style=";font-family:Calibri;font-size:10;color:black;"   &gt;&lt;/span&gt;&lt;/a&gt;&lt;/p&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="PowerPoint.Slide"&gt;&lt;meta name="Generator" content="Microsoft PowerPoint 12"&gt;&lt;span style=";font-family:Calibri;font-size:10;color:black;"   &gt;&lt;/span&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; direction: ltr; unicode-bidi: embed;"&gt;&lt;span style="color: rgb(0, 0, 102);font-family:Calibri;font-size:100%;"  &gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; direction: ltr; unicode-bidi: embed;"&gt;&lt;span style="color: rgb(0, 0, 102);font-family:Calibri;font-size:100%;"  &gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="PowerPoint.Slide"&gt;&lt;meta name="Generator" content="Microsoft PowerPoint 12"&gt;  &lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; direction: ltr; unicode-bidi: embed; color: rgb(0, 0, 102);"&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt;Transporte coletivo é um exemplo bem freqüente, a falta de infra estrutura no setor ocasiona o super &lt;/span&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt;lotamento&lt;/span&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt; &lt;/span&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt;nos &lt;/span&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt;transportes coletivos das grandes cidades e as pessoas se amontoam,obstruindo a passagem de outras.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: right; direction: ltr; unicode-bidi: embed; color: rgb(0, 0, 102);"&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: right; direction: ltr; unicode-bidi: embed; color: rgb(0, 0, 102);"&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: right; direction: ltr; unicode-bidi: embed; color: rgb(0, 0, 102);"&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt;&lt;span style="color: rgb(0, 0, 0);"&gt;Postado por:&lt;/span&gt;&lt;span style="color: rgb(153, 51, 153); font-weight: bold;"&gt;ALEXSANDRA SOUZA&lt;/span&gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; direction: ltr; unicode-bidi: embed; color: rgb(0, 0, 102);"&gt;
&lt;br /&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; direction: ltr; unicode-bidi: embed; color: rgb(0, 0, 102);"&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt;
&lt;br /&gt;&lt;/span&gt;&lt;span style=";font-family:Calibri;font-size:130%;"  &gt; &lt;/span&gt;&lt;/p&gt;  &lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; direction: ltr; unicode-bidi: embed; color: rgb(0, 0, 102);"&gt;&lt;span style="color: rgb(0, 0, 102);font-family:Calibri;font-size:130%;"  &gt;
&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify; direction: ltr; unicode-bidi: embed;"&gt;&lt;span style="color: rgb(0, 0, 102);font-family:Calibri;font-size:130%;"  &gt;&lt;/span&gt;&lt;span style="color: rgb(0, 0, 102);font-family:Calibri;font-size:100%;"  &gt;
&lt;br /&gt;&lt;/span&gt;&lt;span style=";font-family:Calibri;font-size:13;color:black;"   &gt; &lt;/span&gt;&lt;/p&gt;  &lt;div style="text-align: justify;"&gt;  &lt;span style=";font-family:Arial;font-size:85%;color:black;"   &gt;&lt;/span&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiNmhvMrL5yo64bT-Hi-m1fkePGSRl83QLnA2fejSNVSaBOayHoXA0Ec9Tq3BZIqiKGwjjrcnL7PZ_dFKbO9hGwDNHYmwxxbVrIysr0l_Vm9xy2AL0bxxo6DkCgeygxJdW_1zX1LktCksok/s72-c/linfa.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Autismo: ainda um enigma</title><link>http://biompato.blogspot.com/2010/06/autismo-ainda-um-enigma.html</link><category>autismo</category><category>disturbios</category><category>doenças neurológicas</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Wed, 9 Jun 2010 09:30:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-5732125631942007561</guid><description>&lt;div style="text-align: justify;"&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYZgFQvrikkgXi0_xta4hYS-CK9TlhTBr6tZUGtNdPO_78TsMW6PUHnQEN4d_uqIaSsbYYrOFNUhTT4L6GL5y0AARLKUYNPrEfRVFrOhEpADLJoa08y6qe0CeD7rmvYAkJ7Z_8kyGxJ8pO/s1600/capa270.jpg"&gt;&lt;img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 157px; height: 212px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYZgFQvrikkgXi0_xta4hYS-CK9TlhTBr6tZUGtNdPO_78TsMW6PUHnQEN4d_uqIaSsbYYrOFNUhTT4L6GL5y0AARLKUYNPrEfRVFrOhEpADLJoa08y6qe0CeD7rmvYAkJ7Z_8kyGxJ8pO/s320/capa270.jpg" alt="" id="BLOGGER_PHOTO_ID_5480754802689604130" border="0" /&gt;&lt;/a&gt;&lt;span style="font-weight: bold;"&gt;Há mais de 70 anos, cientistas estudam aquela que é uma das mais enigmáticas desordens neurológicas: o autismo. Os mecanismos do distúrbio permanecem em grande parte desconhecidos, mas novos estudos indicam caminhos mais eficazes para tratá-lo.&lt;/span&gt;&lt;/div&gt;&lt;p style="text-align: justify;"&gt;“Ele vive no seu próprio mundo.” A frase é bastante utilizada para descrever de forma leviana pessoas distraídas, que dão pouca atenção ao que acontece ao seu redor. As mesmas palavras, entretanto, ganham um significado muito mais enfático quando se referem a um portador de autismo – uma desordem neurológica manifestada por uma tríade de sintomas: déficit de interação social, dificuldade de linguagem e comportamento repetitivo.&lt;/p&gt;&lt;p style="font-weight: bold; text-align: justify;"&gt;No Brasil, não há uma estimativa oficial do governo de casos de autismo na população e, para fins estatísticos, utilizam-se dados extrapolados de instituições estrangeiras, como o Centro de Controle e Prevenção de Doenças dos EUA (CDC). Segundo um relatório de 2006 desse instituto, uma em cada 110 crianças é portadora de uma desordem do espectro autista. O número parece bastante alto, mas os critérios do instituto provavelmente englobam muitos níveis de autismo, inclusive os mais leves.&lt;/p&gt;&lt;p style="text-align: justify;"&gt;Por:&lt;span style="font-weight: bold;"&gt; &lt;/span&gt;&lt;span&gt;&lt;span style="font-weight: bold;"&gt;Isabela Fraga&lt;/span&gt;  -REVISTA CIÊNCIA HOJE &lt;/span&gt; &lt;/p&gt;&lt;div style="text-align: justify;"&gt;                          &lt;/div&gt;&lt;p size="11px" style="text-align: justify;"&gt;           &lt;span&gt;             Publicado em &lt;span style="font-weight: bold;"&gt;17/05/2010&lt;/span&gt;           &lt;/span&gt;            &lt;span&gt;|            Atualizado em &lt;span&gt; &lt;span style="font-weight: bold;"&gt;24/05/2010&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: right;"&gt;&lt;span&gt;&lt;span&gt;Postado por: &lt;span style="font-weight: bold;"&gt;ALEXSANDRA SOUZA&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;p style="font-size: 11px; text-align: justify;"&gt;&lt;span&gt;          &lt;/span&gt;         &lt;/p&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYZgFQvrikkgXi0_xta4hYS-CK9TlhTBr6tZUGtNdPO_78TsMW6PUHnQEN4d_uqIaSsbYYrOFNUhTT4L6GL5y0AARLKUYNPrEfRVFrOhEpADLJoa08y6qe0CeD7rmvYAkJ7Z_8kyGxJ8pO/s72-c/capa270.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>2º PATHOSCÓPIO-Expondo Conceitos de Patologia, por uma Consciência Social.</title><link>http://biompato.blogspot.com/2010/06/2-pathoscopio-expondo-conceitos-de.html</link><category>alunos</category><category>Faculdade Leão Sampaio</category><category>pathoscópio</category><category>patologia</category><category>trabalhos</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Tue, 8 Jun 2010 10:05:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-1904563734288337747</guid><description>&lt;div style="text-align: justify; font-weight: bold; color: rgb(0, 102, 0);"&gt;Encontram-se expostos trabalhos   feitos pelos alunos da Faculdade Leão Sampaio,incentivados pelo professor da disciplina de Patologia &lt;span style="font-weight: bold;"&gt;Flávio Furtado de Farias &lt;/span&gt;com temas bastantes interessantes onde mostra situações do nosso cotidiano relacionados a patologias.Para quem ainda não viu vale a pena conferir.&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: right;"&gt;                                    &lt;br /&gt; &lt;span style="color: rgb(0, 51, 0);"&gt; Postado por:&lt;/span&gt; &lt;span style="color: rgb(51, 204, 0);"&gt;ALEXSANDRA SOUZA&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;</description><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>CITOPATOLOGIA E HPV</title><link>http://biompato.blogspot.com/2010/05/citopatologia-e-hpv.html</link><author>noreply@blogger.com (Biopatologia)</author><pubDate>Sun, 30 May 2010 23:48:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-8105584029500575021</guid><description>&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiQRA7IM4XO1dy5VK7K3J7-lN9F7iihWhmqfQj9AMcwp-NL6NaELF89H047ZQWdWClJgUB4K-4eoHu98XNSG-7_cBWNlMJs9s6P7Ny6oSCcmshDkhWRhqp25_ASUaS5XqJTLkCfHJoX5PVd/s1600/hpv-virus%5B1%5D.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 359px; DISPLAY: block; HEIGHT: 327px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5477268140766003314" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiQRA7IM4XO1dy5VK7K3J7-lN9F7iihWhmqfQj9AMcwp-NL6NaELF89H047ZQWdWClJgUB4K-4eoHu98XNSG-7_cBWNlMJs9s6P7Ny6oSCcmshDkhWRhqp25_ASUaS5XqJTLkCfHJoX5PVd/s320/hpv-virus%5B1%5D.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#990000;"&gt;&lt;strong&gt;PAPILOMA VÍRUS HUMANO, é assim caracterizado o HPV.&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#993300;"&gt;&lt;strong&gt;São vírus da família Papilomaviridae&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#660000;"&gt;&lt;strong&gt;Os de alto risco estão relacionados com os tumores malignos&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;span style="font-family:Arial;font-size:130%;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt; &lt;/div&gt;&lt;strong&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 223px; DISPLAY: block; HEIGHT: 239px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5477265886261022354" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjeNaT1qIObzAY7WcmgDs7JuRNkUID3G38fQ0qLlwORcyrzPRYBoA2DsxBwrStp6YjfJptkJLwZkyntj9XZ4_PVJb6_THRrm1lJCsEI51yQIZTEqelkjAxnnCJOtl1vfzNPcVhoSBjlQjXZ/s320/img_617_0%5B1%5D.jpg" /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#660000;"&gt;&lt;strong&gt;Habitualmente são detectados e extintos pelo sistema imune.&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#993300;"&gt;&lt;strong&gt;A transmissão é o contato direto com a pele infectada.&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#996633;"&gt;&lt;strong&gt;Os HPV genitais são transmitidos por relações sexuais.&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;span style="font-family:Arial;font-size:130%;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;strong&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 216px; DISPLAY: block; HEIGHT: 211px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5477266362645123906" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEirGdARZNIewvFb3bTGko-d21TUKwtngz9qYpZx2ltNUSXrqQUoxDbZDR1ejtOdMo2gH-o7PltFmuY307zE0gGbvUCA4ZvibjSaRty1cIRDXPkTKpVGoKxgiujIlaL7S2CjtVEoiak5T_Ap/s320/untitled.bmp" /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#660000;"&gt;&lt;strong&gt;Aparecem como verrugas, ou condiloma acuminado.&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#993300;"&gt;&lt;strong&gt;O diagnóstico clínico se dá pela citopatologia, que identifica vestígios-pré do HPV.&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#996633;"&gt;&lt;strong&gt;SUS - Tem exames gratuitos!&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;strong&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 217px; DISPLAY: block; HEIGHT: 198px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5477266668481031250" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgoaCP-2LuRdH3Ds4RJOzRyIABFSdbF_2a85TniZDBlNeW6oCbjWta0XyWl-J6YXwji4ht1vODMI6mcUonKKaSFwg0s7o_-xDacXKRVJ3Ku2u5KM8RS9vsi6No0hc2Kc1aXQVLTHFfpouLp/s320/vogue+1940+estudo%5B1%5D.jpg" /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;div align="center"&gt;&lt;span style="font-family:arial;font-size:130%;color:#990000;"&gt;&lt;strong&gt;Exitem vacinas que previnem o HPV que estimulam os anticorpos específicos para cada papiloma vírus.&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;span style="font-size:130%;color:#990000;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="left"&gt;&lt;span style="font-family:times new roman;font-size:130%;"&gt;&lt;em&gt;Émerson de Oliveira&lt;/em&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;em&gt;&lt;span style="font-family:Times New Roman;font-size:130%;"&gt;&lt;/span&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align="left"&gt;&lt;em&gt;&lt;span style="font-family:Times New Roman;font-size:78%;"&gt;Fonte: INCA. Instituto Nacional do Câncer - Ministério da Saúde - Brasil&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiQRA7IM4XO1dy5VK7K3J7-lN9F7iihWhmqfQj9AMcwp-NL6NaELF89H047ZQWdWClJgUB4K-4eoHu98XNSG-7_cBWNlMJs9s6P7Ny6oSCcmshDkhWRhqp25_ASUaS5XqJTLkCfHJoX5PVd/s72-c/hpv-virus%5B1%5D.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>CITOPATOLOGIA, O INÍCIO.</title><link>http://biompato.blogspot.com/2010/05/citopatologia-o-inicio.html</link><category>CITOPATOLOGIA</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Sun, 30 May 2010 23:14:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-535722379084486178</guid><description>&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEju9jWAFTHLgo9GEsxhjYvhNMXgLERjcFvRplkAFrKkmxQm-IPJG0dhYd9tExeAaXU4PSV819oI1fQh_CMi5-MmA971xl_K3f6jr7kbsrNTCniof5dLLUoqtL6zDKc1iSBYwwlVuwwaYFRZ/s1600/img_ilustra_oncologico01%5B1%5D.jpg"&gt;&lt;img style="MARGIN: 0px 0px 10px 10px; WIDTH: 194px; FLOAT: right; HEIGHT: 271px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5477258131370852562" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEju9jWAFTHLgo9GEsxhjYvhNMXgLERjcFvRplkAFrKkmxQm-IPJG0dhYd9tExeAaXU4PSV819oI1fQh_CMi5-MmA971xl_K3f6jr7kbsrNTCniof5dLLUoqtL6zDKc1iSBYwwlVuwwaYFRZ/s320/img_ilustra_oncologico01%5B1%5D.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;em&gt;A &lt;strong&gt;Citopatologia&lt;/strong&gt;, estuda a &lt;strong&gt;doença&lt;/strong&gt; a nível &lt;strong&gt;celular.&lt;/strong&gt; O comportamento morfológico, bioquímico, molecular, é categoricamente a fonte de comprovação para determinadas alterações que podem diagnosticar uma doença. Com a vantagem de fácil obtenção das amostras, a citopatologia, mesmo ainda considerada metodologicamente invasiva, se sobressai, comparando-se a biópsias realizadas para obtenção de tecidos celulares, onde se dá a necessidade de procedimentos cirúrgicos mais complexos. &lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;Hoje em dia, o &lt;strong&gt;biomédico&lt;/strong&gt;, assim &lt;strong&gt;especializado&lt;/strong&gt;, tem competência de emitir laudos correspondentes as amostras provindas da &lt;strong&gt;tireóide, mama, colo do útero e líquidos cavitários.&lt;/strong&gt; A citopatologia tem carácter também &lt;strong&gt;preventivo&lt;/strong&gt;, como um exame muito conhecido do colo do útero; &lt;strong&gt;"Papanicolau"&lt;/strong&gt;, identifando os fatores que concorrem pra certas neoplasias ginecológicas, como no caso do vilão &lt;strong&gt;HPV&lt;/strong&gt;. Se de início for detectado, as complicações severas podem ser remediadas com eficácia.&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;/em&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;Émerson de Oliveira&lt;/em&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEju9jWAFTHLgo9GEsxhjYvhNMXgLERjcFvRplkAFrKkmxQm-IPJG0dhYd9tExeAaXU4PSV819oI1fQh_CMi5-MmA971xl_K3f6jr7kbsrNTCniof5dLLUoqtL6zDKc1iSBYwwlVuwwaYFRZ/s72-c/img_ilustra_oncologico01%5B1%5D.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Osteoporose</title><link>http://biompato.blogspot.com/2010/05/osteoporose.html</link><category>musculação</category><category>osteoclásto</category><category>osteoporose</category><category>tecido</category><category>ósseo</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Sat, 29 May 2010 15:50:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-5554289653467596425</guid><description>&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiVfmU9wepMQOxpJOi7h57wSqFLxjZK3k4SYcRYruPpPBvxqQgc0H0ncHsu0pBoRDycFjCdvykVVSpba2Rws4KYsFc28BLuRxQ3umaaG_ghdx5m1hezIFiA-kW5FFyaJGs3HXJGSDxU_Mhk/s1600/osteoporose_analise.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 352px; DISPLAY: block; HEIGHT: 241px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5476777798307417762" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiVfmU9wepMQOxpJOi7h57wSqFLxjZK3k4SYcRYruPpPBvxqQgc0H0ncHsu0pBoRDycFjCdvykVVSpba2Rws4KYsFc28BLuRxQ3umaaG_ghdx5m1hezIFiA-kW5FFyaJGs3HXJGSDxU_Mhk/s320/osteoporose_analise.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="color:#000000;"&gt;É a mais comum de todas as osteopatias nos adultos, especialmente em indivúduos com idade avançada e resulta da diminuição da matriz óssea orgânica. Na osteoporose, a atividade osteoblástica no osso costuma estar abaixo do normal e, como consequência, a taxa de deposição de osteóide encontra-se deprimida. Ocasionalmente, no entanto, a causa da diminuição óssea é o excesso da atividade osteoclástica.&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;span style="color:#3333ff;"&gt;As causas mais comuns da osteoporose são:&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#3333ff;"&gt;Falta de estresse físico sobre os ossos em função da inatividade;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="color:#3333ff;"&gt;Deficiência de vitamina C;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="color:#3333ff;"&gt;Falta de secreção do estrogênio no período pós-menoupasa;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="color:#3333ff;"&gt;Idade Avançada;&lt;/span&gt;&lt;/li&gt;&lt;br /&gt;&lt;li&gt;&lt;span style="color:#3333ff;"&gt;Síndrome de Cushing&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;&lt;p&gt;&lt;span style="color:#ff6600;"&gt;&lt;strong&gt;É verdade que a musculação ajuda no tratamento e prevenção da osteoporose?&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;br /&gt;&lt;p align="center"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgK6CGMHTGlG-qfwPuERtSCPK56rGcXzmmVFriem3_Au51wxLD9EKhCZo1nHuXf1n5JctbVxVQs9Ncb4KRJRmpnwY4X4VCEFF354aWxmNHv6SALWOzUldYLnxNWzLue7GQncbvstt_UK-xJ/s1600/osteoporose.jpg"&gt;&lt;img style="WIDTH: 320px; HEIGHT: 300px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5476771874587483698" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgK6CGMHTGlG-qfwPuERtSCPK56rGcXzmmVFriem3_Au51wxLD9EKhCZo1nHuXf1n5JctbVxVQs9Ncb4KRJRmpnwY4X4VCEFF354aWxmNHv6SALWOzUldYLnxNWzLue7GQncbvstt_UK-xJ/s320/osteoporose.jpg" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;br /&gt;&lt;p align="justify"&gt;&lt;span style="font-family:arial;color:#ff0000;"&gt;Segundo as recomendações do Colégio Americano de Medicina Desportiva (ACSM), citadas por Katch F., Katch V. e Mcardle (1998), os exercícios selecionados para atuações profiláticas e terapêuticas contra a osteoporose devem ser aqueles que proporcionam o aprimoramento das valências físicas força e flexibilidade. É neste ponto que a prática da musculação interfere com maior intensidade, pois sabe-se que os exercícios contra resistência atuam positivamente na melhoria da capacidade contrátil dos músculos esqueléticos, assim como também geram efeitos positivos na elasticidade muscular em decorrência da proliferação de tecido conjuntivo ocasionada pela hipertrofia (Santarém, 2000 a). As melhorias em força e flexibilidade são acompanhadas pelo aumento da densidade óssea mineral, deixando o sistema esquelético mais forte e mais resistente a fraturas e deformações. Desta forma a musculação pode ser considerada o mais eficiente estímulo ambiental na prevenção e no tratamento da osteoporose, melhorando significativamente a qualidade de vida de todas as pessoas que são obrigadas a conviver com este tipo de problema. &lt;/span&gt;&lt;/p&gt;&lt;br /&gt;&lt;p align="justify"&gt;&lt;span style="font-family:Arial;font-size:78%;color:#000000;"&gt;Referências&lt;/span&gt;&lt;/p&gt;&lt;p align="justify"&gt;&lt;span style="font-size:78%;"&gt;GUYTON &amp;amp; HALL, 2006&lt;/span&gt;&lt;/p&gt;&lt;p align="justify"&gt;&lt;span style="font-size:78%;"&gt;KATCH, Frank., KATCH, Víctor., MCARDLE, William. Fisiologia do exercício: energia, nutrição e desempenho humano. 4 ed. Rio de Janeiro: guanabara koogan, 1998.&lt;/span&gt;&lt;/p&gt;&lt;p align="right"&gt;&lt;span style="font-size:78%;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p align="right"&gt;&lt;span style="font-size:78%;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;br /&gt;&lt;p align="right"&gt;&lt;strong&gt;&lt;em&gt;Postado por: Pedro Antonione&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiVfmU9wepMQOxpJOi7h57wSqFLxjZK3k4SYcRYruPpPBvxqQgc0H0ncHsu0pBoRDycFjCdvykVVSpba2Rws4KYsFc28BLuRxQ3umaaG_ghdx5m1hezIFiA-kW5FFyaJGs3HXJGSDxU_Mhk/s72-c/osteoporose_analise.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Caso tenha câncer: Há esperança para você!</title><link>http://biompato.blogspot.com/2010/05/caso-tenha-cancer-ha-esperanca-para.html</link><author>noreply@blogger.com (Biopatologia)</author><pubDate>Tue, 25 May 2010 00:50:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-2023896689972934578</guid><description>&lt;div align="center"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEguaitwkoUE3iWykBjX_xKxevABZeWj3d-V4ZXArwByZ18fwaValYG1D0HTPDnlFfCHDpl1FzP_OD59LNkQNmv_d8mdybdAAmushIPy3RQUn25v21_XuayA4v473-PUCr0kptxpV6aR5Sdc/s1600/BXK16358_flor-com-gotas-agua800%5B1%5D.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 339px; DISPLAY: block; HEIGHT: 243px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5475061201382606562" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEguaitwkoUE3iWykBjX_xKxevABZeWj3d-V4ZXArwByZ18fwaValYG1D0HTPDnlFfCHDpl1FzP_OD59LNkQNmv_d8mdybdAAmushIPy3RQUn25v21_XuayA4v473-PUCr0kptxpV6aR5Sdc/s320/BXK16358_flor-com-gotas-agua800%5B1%5D.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Muito é falado que a qualidade de vida, e o querer se manter bem "autoestima", ajuda na recuperação e até mesmo na cura do câncer. É claro que o sofrimento se torna mais leve quando a fé assegura uma nova esperança a cada dia. Apesar que não há estudos que comprovem essa realidade a nível molecular e orgânico. Veja, a questão da neoplasia que pode ser benigna ou malígna, se desenrrola na capacidade potente de proliferação celular; e essa desordem costura um tecido remendado, deixando o orgão ou membro atingido morfologicamente e metabolicamente anormal. Até então, é importante deixar claro que o paciente com câncer não será tratado somente do câncer! Mas todo um conjunto de doenças virão como prejuízos psicológicos e até mesmo a cascata desenfreada de mitoses e ações disparadas do metabolismo desrregulado. &lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;&lt;/div&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt; &lt;/div&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Com&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhr6c5u8e201giBDbVDRps8_whJrbfw7Rs2hkpU2ryhwhiTiwlBp0I3566ij37RcPGq7NozoC3vTVBaYBqjW6fnaNLYn5Jm49TIK26wofVcv6cZvZJcdg6dF29WrKU5dKlz_-QgTYAaITpm/s1600/23_MHG_voz1_2206%5B1%5D.jpg"&gt;&lt;img style="MARGIN: 0px 10px 10px 0px; WIDTH: 125px; FLOAT: left; HEIGHT: 148px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5475062388004811490" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhr6c5u8e201giBDbVDRps8_whJrbfw7Rs2hkpU2ryhwhiTiwlBp0I3566ij37RcPGq7NozoC3vTVBaYBqjW6fnaNLYn5Jm49TIK26wofVcv6cZvZJcdg6dF29WrKU5dKlz_-QgTYAaITpm/s320/23_MHG_voz1_2206%5B1%5D.jpg" /&gt;&lt;/a&gt;o pesquisador, não vi ainda uma confirmação de que o otimismo ajuda na " irreverssibilidade " da origem e crescimento tumoral, infatizo mais uma vez: A nível molecular, bioquímico, celular, " Na raiz do problema". Mas como pesquisador otimista eu creio, que as pesquisas ainda podem avançar nesse sentido. &lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Vemos claramente no evangelho: "Senhor, se quiseres, podes me curar. Jesus disse: Eu quero, sê limpo" O dom da fé é um mistério. Falo isso sem medo como cientista. Caso tenha câncer: Há esperança para você! Falo isso por que Eu Émerson, já Vi um cego de nascença enxergar milagrosamente depois de 35 anos, pelo o poder de Jesus. De todas essas coisas atesto veracidade e parecer de fé!&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;/em&gt;&lt;div align="right"&gt;&lt;em&gt;Emerson de Oliveira&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEguaitwkoUE3iWykBjX_xKxevABZeWj3d-V4ZXArwByZ18fwaValYG1D0HTPDnlFfCHDpl1FzP_OD59LNkQNmv_d8mdybdAAmushIPy3RQUn25v21_XuayA4v473-PUCr0kptxpV6aR5Sdc/s72-c/BXK16358_flor-com-gotas-agua800%5B1%5D.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Alerta à resultado Falso-Positivo...</title><link>http://biompato.blogspot.com/2010/05/alerta-resultado-falso-positivo.html</link><category>AIDS</category><category>falso-positivo</category><category>gripe suína</category><category>Influenza A</category><category>vacina</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Mon, 24 May 2010 10:09:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-2931062755418418088</guid><description>&lt;span style="font-size:100%;"&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiZGFpKIhxotJTPoJBhDZlb0hd_Bm3ipYy2evx_28fGVe5hYwXkdoMxj6yn_FghawQYLTyu9cJj__VtcOZAN_3Qr8mtH5UjFrw3ZQGkfNUAtqZF-Js5vJXhduoqizXP92nepFDaHeaJI-Ad/s1600/meiobit-hiv_tn.jpg"&gt;&lt;img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 200px; height: 200px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiZGFpKIhxotJTPoJBhDZlb0hd_Bm3ipYy2evx_28fGVe5hYwXkdoMxj6yn_FghawQYLTyu9cJj__VtcOZAN_3Qr8mtH5UjFrw3ZQGkfNUAtqZF-Js5vJXhduoqizXP92nepFDaHeaJI-Ad/s320/meiobit-hiv_tn.jpg" alt="" id="BLOGGER_PHOTO_ID_5474835385196393346" border="0" /&gt;&lt;/a&gt;
&lt;br /&gt;&lt;/span&gt;&lt;div style="text-align: justify;"&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 12"&gt;&lt;meta name="Originator" content="Microsoft Word 12"&gt;&lt;link rel="File-List" href="file:///C:%5CDOCUME%7E1%5CGeral%5CCONFIG%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml"&gt;&lt;link rel="themeData" href="file:///C:%5CDOCUME%7E1%5CGeral%5CCONFIG%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx"&gt;&lt;link rel="colorSchemeMapping" href="file:///C:%5CDOCUME%7E1%5CGeral%5CCONFIG%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT-BR&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="--"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:roman; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0cm; 	margin-right:0cm; 	margin-bottom:10.0pt; 	margin-left:0cm; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi; 	mso-fareast-language:EN-US;} a:link, span.MsoHyperlink 	{mso-style-priority:99; 	color:blue; 	mso-themecolor:hyperlink; 	text-decoration:underline; 	text-underline:single;} a:visited, span.MsoHyperlinkFollowed 	{mso-style-noshow:yes; 	mso-style-priority:99; 	color:purple; 	mso-themecolor:followedhyperlink; 	text-decoration:underline; 	text-underline:single;} span.f 	{mso-style-name:f; 	mso-style-unhide:no;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi; 	mso-fareast-language:EN-US;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:595.3pt 841.9pt; 	margin:70.85pt 3.0cm 70.85pt 3.0cm; 	mso-header-margin:35.4pt; 	mso-footer-margin:35.4pt; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Tabela normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin-top:0cm; 	mso-para-margin-right:0cm; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0cm; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:"Times New Roman"; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;/div&gt;&lt;p style="text-align: justify;" class="MsoNormal"&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:100%;"  &gt;Em nota aos profissionais da saúde, o Departamento de Doenças Sexualmente Transmissíveis, AIDS e Hepatites Virais do Ministério da Saúde já havia alertado que anticorpos gerados pela vacina contra a Influenza A podem ser confundidos com o vírus HIV. Com isso, os resultados dos testes de HIV em pessoas que tomaram a vacina contra a Influenza A (H1N1) poderia ter resultados falso-positivos.&lt;span style="color: rgb(74, 74, 74);"&gt; O problema do falso resultado positivo acontece porque a vacina contra aumenta a produção de um anticorpo, chamado de IgM (o primeiro batalhão de defesa do organismo), que confunde o teste mais comum feito no Brasil, o Elisa. &lt;/span&gt;&lt;cite&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/cite&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify;" class="MsoNormal"&gt;&lt;span style="line-height: 115%;font-family:&amp;quot;;font-size:100%;"  &gt;Segundo Lilian Inocêncio, todos os exames de HIV passam por um teste comprobatório no qual é usado um método de análise diferente do primeiro. "Existe uma normativa que determina que todos os laboratórios de saúde pública e privada façam um novo teste em casos de resultado positivo. A pessoa que fizer o teste não vai ser informada, o próprio laboratório deve realizar o teste confirmatório". De acordo com a assessora, as pessoas não devem deixar de tomar a vacina contra a Influenza A (H1N1) – gripe A. Este alerta foi direcionado apenas aos profissionais de saúde e teve o objetivo de descartar a possibilidade de exames com resultados falso-positivos chegarem aos pacientes. "Não existe nenhum risco com relação à vacina contra a Influenza A (H1N1), pedimos que todos sejam imunizados. Além disso, tomar a vacina não impede que o teste de HIV seja feito, se necessário", alertou.
&lt;br /&gt; &lt;!--[if !supportLineBreakNewLine]--&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify;" class="MsoNormal"&gt;&lt;span style="font-size:100%;"&gt;&lt;cite&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/cite&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p style="text-align: justify;" class="MsoNormal"&gt;&lt;span style="font-size:100%;"&gt;&lt;cite&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;span style="font-weight: bold;"&gt;FONTE:&lt;/span&gt; vidadeumaborderline.blogspot.com/.../&lt;b&gt;vacina&lt;/b&gt;-contra-&lt;b&gt;gripe&lt;/b&gt;-h1n1-&lt;b&gt;vs&lt;/b&gt;-teste-de.&lt;wbr&gt;html&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/cite&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;span style="font-size:100%;"&gt;&lt;a href="http://www.jornalvs.com.br/.../geral,canal-8,ed-60,ct-978,cd-261089.htm"&gt;&lt;span style="font-style: normal;"&gt;www.jornalvs.com.br/.../geral,canal-8,ed-60,ct-978,cd-261089.htm&lt;/span&gt;&lt;/a&gt;
&lt;br /&gt;&lt;cite&gt;&lt;/cite&gt;
&lt;br /&gt;&lt;cite&gt;&lt;span style=";font-family:&amp;quot;;" &gt;br24h.com/quem-tomou-&lt;b&gt;vacina&lt;/b&gt;-&lt;b&gt;gripe&lt;/b&gt;-a-exame-da-&lt;b&gt;hiv&lt;/b&gt;-positivo&lt;/span&gt;&lt;/cite&gt;&lt;/span&gt;&lt;span class="f"  style="font-size:100%;"&gt; -
&lt;br /&gt;
&lt;br /&gt;&lt;/span&gt;&lt;div style="text-align: right;"&gt;&lt;span class="f"  style="font-size:100%;"&gt;Postado por: &lt;span style="color: rgb(102, 51, 102); font-weight: bold;"&gt;ALEXSANDRA SOUZA&lt;/span&gt;&lt;/span&gt;
&lt;br /&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-align: justify;" class="MsoNormal"&gt;&lt;span style="font-size:100%;"&gt;&lt;cite&gt;&lt;/cite&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify;" class="MsoNormal"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.jornalvs.com.br/.../geral,canal-8,ed-60,ct-978,cd-261089.htm"&gt;&lt;span style="font-style: normal;"&gt;
&lt;br /&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify;" class="MsoNormal"&gt;&lt;span style="font-size:100%;"&gt;&lt;cite&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/cite&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p style="text-align: justify;" class="MsoNormal"&gt;&lt;span style="font-size:100%;"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiZGFpKIhxotJTPoJBhDZlb0hd_Bm3ipYy2evx_28fGVe5hYwXkdoMxj6yn_FghawQYLTyu9cJj__VtcOZAN_3Qr8mtH5UjFrw3ZQGkfNUAtqZF-Js5vJXhduoqizXP92nepFDaHeaJI-Ad/s72-c/meiobit-hiv_tn.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>FORMA DE CUNHA</title><link>http://biompato.blogspot.com/2010/05/forma-de-cunha.html</link><category>FORMA DE CUNHA</category><category>INFARTO</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Sun, 23 May 2010 00:20:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-295151225761796926</guid><description>&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhV0feR4aXuPoT3Mr4MUNrOcWuEJuySA0sDbz9nrEbX80t6VjGJhuA36OHWLybkgRUyyu1-QPaYmWgYHH5Mnj-iU-IHW7X-t0ONONJlyadO1UdxmPOonTzAjHKsiLRPoSchS6XaGWt91upH/s1600/avenca_3.2%5B1%5D.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 345px; DISPLAY: block; HEIGHT: 356px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5474302369950419618" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhV0feR4aXuPoT3Mr4MUNrOcWuEJuySA0sDbz9nrEbX80t6VjGJhuA36OHWLybkgRUyyu1-QPaYmWgYHH5Mnj-iU-IHW7X-t0ONONJlyadO1UdxmPOonTzAjHKsiLRPoSchS6XaGWt91upH/s320/avenca_3.2%5B1%5D.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="color:#000099;"&gt;&lt;strong&gt;Os infartos em qualquer que sejam os tecidos, apresentam uma forma de cunha, como uma pirâmide até, dependendo da interpretação e bom senso do olhar do patologista. Essa pirâmide pode estar até invertida, conforme a árvore vascular se anastomosa e abre os caminho para a nobre corrente sanguínea. Aliás, dependendo do tipo de infarto, nem sempre essa cunha terá a visita do nobre sangue! "&lt;/strong&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="color:#000099;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="color:#000099;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 230px; DISPLAY: block; HEIGHT: 217px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5474302848985983378" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhR7UCUdK7if393x-qswa791bQzjKoM8aHeq_0_chkzCb5PhbcFZFqNmFfpeylX-NXu4Up_XKy2sdSh0Njgc-Mzjb0BrdkJt0G6_AaQMm0gkGHrLwWwmMkNW3Kq5VHuGDFXmCC5BENZZcOs/s320/gengivitis_infarto_2%5B1%5D.gif" /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000099;"&gt;" A maioria dos infartos tende a apresentar uma forma de cunha, com o vaso ocluído no ápice e a periferia do órgão formando a base" *Robbins &amp;amp; Cotran&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000099;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;div&gt;&lt;span style="color:#000099;"&gt;Emerson de Oliveira&lt;/span&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhV0feR4aXuPoT3Mr4MUNrOcWuEJuySA0sDbz9nrEbX80t6VjGJhuA36OHWLybkgRUyyu1-QPaYmWgYHH5Mnj-iU-IHW7X-t0ONONJlyadO1UdxmPOonTzAjHKsiLRPoSchS6XaGWt91upH/s72-c/avenca_3.2%5B1%5D.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>NEM SEMPRE INFARTO É NO MIOCARDIO!</title><link>http://biompato.blogspot.com/2010/05/nem-sempre-infarto-e-no-miocardio.html</link><category>INFARTO BRANCO</category><category>INFARTO VERMELHO</category><category>INFATO</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Sat, 22 May 2010 23:36:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-133882827157175081</guid><description>&lt;div align="justify"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiuSEAHGWHUDFLmEgewcJ-i867f1MWEcPrnDjHA714rTAsWNv0AFW2puMZq29FDU4EKN0yymssHuDDh1VULiEL14qVb2RQEPXkGon5NrvJDN4695ZIf5rXW7J6plJ1xc5hNA0JtqN5Yy_Qg/s1600/saude1%5B1%5D.jpg"&gt;&lt;img style="MARGIN: 0px 0px 10px 10px; WIDTH: 161px; FLOAT: right; HEIGHT: 206px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5474294746259748818" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiuSEAHGWHUDFLmEgewcJ-i867f1MWEcPrnDjHA714rTAsWNv0AFW2puMZq29FDU4EKN0yymssHuDDh1VULiEL14qVb2RQEPXkGon5NrvJDN4695ZIf5rXW7J6plJ1xc5hNA0JtqN5Yy_Qg/s320/saude1%5B1%5D.jpg" /&gt;&lt;/a&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="font-size:130%;"&gt;Infarto é um local necrosado por isquemia, tecido esse que foi lesionado pela falta de suprimento de O2 e nutrientes existentes no sangue. Muito é associado o infarto com o orgão cardíaco, mas esse evento deletério pode acontecer em tecidos de outros orgãos como: Cérebro, pulmão e atinge também o intestino que é frequentemente fatal. Esses infartos são gerados por eventos trombóticos ou embólicos, pode ocorrer também &lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style="font-size:130%;"&gt; por vasoespasmo local ou tumores.&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="font-size:180%;color:#993300;"&gt;&lt;strong&gt;CLASSIFICAÇÃO DOS INFARTOS&lt;/strong&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhqhZxgxBmqZvyLXl16YLxvQPa7xhlyHj8ap0eqROYiXAZt_oqhyphenhyphenQTM-Pd7-5ChOyyOQoV69-tZpxzCNFj5zpT1lzzkZpZDBqWZupkQP6dbfJIndpNjMxUL0RrRJLkM3qnwTVyxQl5TsEaE/s1600/infarto+vermelho-+test%C3%ADculo%5B1%5D.jpg"&gt;&lt;img style="MARGIN: 0px 10px 10px 0px; WIDTH: 180px; FLOAT: left; HEIGHT: 139px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5474297882655130418" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhqhZxgxBmqZvyLXl16YLxvQPa7xhlyHj8ap0eqROYiXAZt_oqhyphenhyphenQTM-Pd7-5ChOyyOQoV69-tZpxzCNFj5zpT1lzzkZpZDBqWZupkQP6dbfJIndpNjMxUL0RrRJLkM3qnwTVyxQl5TsEaE/s320/infarto+vermelho-+test%C3%ADculo%5B1%5D.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="font-size:130%;"&gt;&lt;strong&gt;&lt;span style="font-family:arial;font-size:180%;color:#cc0000;"&gt;INFARTOS VERMELHOS&lt;/span&gt;&lt;/strong&gt; - Ocorrem pelo bloqueio sanguíneo em veias,como torção ovariana e alterações em tecidos moles. Essa frouxidão do tecido, permite a irrigação do orgão, mesmo já estando infartado.&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgbsTvqrXQVzQ8xT5kxBt6qgjQOovHjs-PgGl2RfFYSlc3n9np-Yzo79xVri8t3A56pzSabMmYG0VEv8vxqtJT9TbSrWG5Cfnf9VIkTNkmPaf02EIgc8x_M1wlr3FcmwpBkcFu0jEqW_I9T/s1600/Infarto+1%5B1%5D.jpg"&gt;&lt;img style="MARGIN: 0px 10px 10px 0px; WIDTH: 177px; FLOAT: left; HEIGHT: 183px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5474295938357698450" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgbsTvqrXQVzQ8xT5kxBt6qgjQOovHjs-PgGl2RfFYSlc3n9np-Yzo79xVri8t3A56pzSabMmYG0VEv8vxqtJT9TbSrWG5Cfnf9VIkTNkmPaf02EIgc8x_M1wlr3FcmwpBkcFu0jEqW_I9T/s320/Infarto+1%5B1%5D.jpg" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="font-size:130%;"&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="font-size:130%;"&gt;&lt;strong&gt;&lt;span style="font-family:arial;font-size:180%;color:#cc9933;"&gt;INFARTOS BRANCOS&lt;/span&gt;&lt;/strong&gt; - Ocorrem pelo o bloqueio sanguíneo em artérias de órgãos sólidos como: Coração, pâncreas e rim. A rigidez, características desses orgãos, não permite a perfusão sanguínea, deixando o orgão anêmico (pálido).&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;em&gt;&lt;span style="font-size:130%;"&gt;&lt;span style="color:#006600;"&gt;&lt;strong&gt;INFARTOS SÉPTICOS&lt;/strong&gt;&lt;/span&gt; - Grande presença bacteriana se proliferando no local infartado.&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="font-size:130%;"&gt;&lt;strong&gt;&lt;span style="color:#336666;"&gt;INFARTOS ASSÉPTICOS&lt;/span&gt;&lt;/strong&gt; - Sem proliferação bacteriana, sem resposta inflamatória.&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Emerson de Oliveira&lt;/div&gt;&lt;div&gt; &lt;/div&gt;&lt;div&gt;&lt;span style="font-size:78%;"&gt;Fonte: Robbins &amp;amp; Cotran - Bases Patológicas das Doenças&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiuSEAHGWHUDFLmEgewcJ-i867f1MWEcPrnDjHA714rTAsWNv0AFW2puMZq29FDU4EKN0yymssHuDDh1VULiEL14qVb2RQEPXkGon5NrvJDN4695ZIf5rXW7J6plJ1xc5hNA0JtqN5Yy_Qg/s72-c/saude1%5B1%5D.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>EMBOLIA GORDUROSA</title><link>http://biompato.blogspot.com/2010/05/embolia-gordurosa.html</link><category>EMBOLIA GORDUROSA</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Sat, 22 May 2010 16:42:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-3283424262863375926</guid><description>&lt;div align="left"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg-Tac4c8IqEw_GyWF_f42-J-QEyKNEqzmxGGsX2CEI8ynyHn8amp3ksZkI_qU7qH5bPTpi3GJI3xiBz-T7buel_LJVQdAR3s7NaSTwPTTZqKC5boJe4E1g2LJH6shyphenhyphen6Ylkkes6X-yiLdK0/s1600/emboliagordurosa4++%5B1%5D.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 320px; DISPLAY: block; HEIGHT: 229px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5474186796560547378" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg-Tac4c8IqEw_GyWF_f42-J-QEyKNEqzmxGGsX2CEI8ynyHn8amp3ksZkI_qU7qH5bPTpi3GJI3xiBz-T7buel_LJVQdAR3s7NaSTwPTTZqKC5boJe4E1g2LJH6shyphenhyphen6Ylkkes6X-yiLdK0/s320/emboliagordurosa4++%5B1%5D.jpg" /&gt;&lt;/a&gt;                                                                   anatpat.unicamp.br&lt;/div&gt;&lt;div align="center"&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-family:arial;"&gt;&lt;span style="color:#006600;"&gt;&lt;span style="font-size:130%;"&gt;Após fraturas de ossos longos como o fêmur, que tem gordura na sua medula óssea, traumas de tecido adiposo e queimaduras, lançam na corrente sanguínea glóbulos gordurosos, formando uma massa intravascular "êmbolo" que se aloja em vasos muito pequenos, predispondo a eventos tromboembólicos que resultarão em necrose isquêmica "infarto" de tecidos subjacentes. A síndrome embólica gordurosa é caracterizada por insuficiência pulmonar e sintomas neurológicos por ocluir também a microvasculatura cerebral&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-family:Arial;color:#006600;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-family:Arial;color:#006600;"&gt;Émerson de Oliveira&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-family:Arial;color:#006600;"&gt;&lt;/span&gt; &lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-family:Arial;font-size:78%;color:#006600;"&gt;&lt;em&gt;Fonte: Robbins &amp;amp; Cotran Patologia - Bases patológicas das doenças&lt;/em&gt;&lt;/span&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg-Tac4c8IqEw_GyWF_f42-J-QEyKNEqzmxGGsX2CEI8ynyHn8amp3ksZkI_qU7qH5bPTpi3GJI3xiBz-T7buel_LJVQdAR3s7NaSTwPTTZqKC5boJe4E1g2LJH6shyphenhyphen6Ylkkes6X-yiLdK0/s72-c/emboliagordurosa4++%5B1%5D.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Visão geral da Carcinogênese</title><link>http://biompato.blogspot.com/2010/05/visao-geral-da-carcinogenese.html</link><category>carcinogênese</category><category>tumor</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Sat, 22 May 2010 15:50:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-5592726638468909722</guid><description>&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Processo de Carcinogênese&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;p align="center"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiufQzl8a5pFiLmAHXNm7KSuZAAdV6yvEEPqfzR2-cfVgY8sOPhWstSB0TuJSV7t0cpDu_EWPZDR-jseFOOyo872QKnawoX8if_ZU_xDcJbP30tjj1ScKj4nHmODHTOIgazqRug9DA_hMPW/s1600/estagios.gif"&gt;&lt;img style="WIDTH: 264px; HEIGHT: 157px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5474172114740466786" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiufQzl8a5pFiLmAHXNm7KSuZAAdV6yvEEPqfzR2-cfVgY8sOPhWstSB0TuJSV7t0cpDu_EWPZDR-jseFOOyo872QKnawoX8if_ZU_xDcJbP30tjj1ScKj4nHmODHTOIgazqRug9DA_hMPW/s320/estagios.gif" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;/span&gt;&lt;p align="center"&gt;&lt;span style="font-size:78%;color:#3333ff;"&gt;Fonte: Ministério da saúde&lt;/span&gt;&lt;/p&gt;&lt;p align="left"&gt;&lt;span style="font-size:78%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p align="left"&gt;&lt;span style="color:#3333ff;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p align="left"&gt;&lt;span style="color:#3333ff;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p align="left"&gt;&lt;span style="font-size:78%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;Os tumores originam-se de um crescimento clonal de células que possuem mutações ocorridas em quatro classes de genes. Esses incluem os genes supressores do tumor e aqueles que regulam a apoptose e o reparo do DNA.&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;A mutação em um único gene não é suficiente para causar câncer. Normalmente, os atributos fenotípicos característicos de malignidade desenvolvem-se quando múltiplas mutações envolvendo múltiplos genes se acumulam. O acúmulo gradual de mutações e o aumento da malignidade são reportados como progressão tumoral.&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;color:#3333ff;"&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:78%;color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;p&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;&lt;strong&gt;Referências &lt;/strong&gt;&lt;/span&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="font-size:78%;"&gt;Robbins, Patologia básica&lt;/span&gt; &lt;/strong&gt;&lt;p align="right"&gt;&lt;br /&gt;&lt;strong&gt;Posted by: Pedro Antonione&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;/p&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiufQzl8a5pFiLmAHXNm7KSuZAAdV6yvEEPqfzR2-cfVgY8sOPhWstSB0TuJSV7t0cpDu_EWPZDR-jseFOOyo872QKnawoX8if_ZU_xDcJbP30tjj1ScKj4nHmODHTOIgazqRug9DA_hMPW/s72-c/estagios.gif" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Pode ser um sinal de alerta!</title><link>http://biompato.blogspot.com/2010/05/pode-ser-um-sinal-de-alerta.html</link><category>cuidados</category><category>edema</category><category>edema na gravidez</category><category>gravidez</category><category>inchaço</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Fri, 21 May 2010 10:31:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-4551257163428777809</guid><description>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgss4WiEcL6sLQwBJ7N7Hojomh0TP98CPQkOgXYe_iJHdrTvngj2hHlq-ugjonWVDzFpg0VEzK6N6_zxWRVJje4hkUusKWU9rMiL0jv0nLqkbZyH1m5Fq36CcgnyA48b1BneMrJ2H5yKMgT/s1600/25zqkgg.jpg"&gt;&lt;img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 256px; height: 320px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgss4WiEcL6sLQwBJ7N7Hojomh0TP98CPQkOgXYe_iJHdrTvngj2hHlq-ugjonWVDzFpg0VEzK6N6_zxWRVJje4hkUusKWU9rMiL0jv0nLqkbZyH1m5Fq36CcgnyA48b1BneMrJ2H5yKMgT/s320/25zqkgg.jpg" alt="" id="BLOGGER_PHOTO_ID_5473718569579022402" border="0" /&gt;&lt;/a&gt;
&lt;br /&gt;&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 12"&gt;&lt;meta name="Originator" content="Microsoft Word 12"&gt;&lt;link rel="File-List" href="file:///C:%5CDOCUME%7E1%5CGeral%5CCONFIG%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml"&gt;&lt;link rel="themeData" href="file:///C:%5CDOCUME%7E1%5CGeral%5CCONFIG%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx"&gt;&lt;link rel="colorSchemeMapping" href="file:///C:%5CDOCUME%7E1%5CGeral%5CCONFIG%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:hyphenationzone&gt;21&lt;/w:HyphenationZone&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;PT-BR&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="--"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:0 0 0 0 0 0 0 0 0 0; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0cm; 	margin-right:0cm; 	margin-bottom:10.0pt; 	margin-left:0cm; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi; 	mso-fareast-language:EN-US;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi; 	mso-fareast-language:EN-US;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:612.0pt 792.0pt; 	margin:70.85pt 3.0cm 70.85pt 3.0cm; 	mso-header-margin:36.0pt; 	mso-footer-margin:36.0pt; 	mso-paper-source:0;} div.Section1 	{page:Section1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Tabela normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0cm 5.4pt 0cm 5.4pt; 	mso-para-margin-top:0cm; 	mso-para-margin-right:0cm; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0cm; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:"Times New Roman"; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;p class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:12;"  &gt;A notícia de que tem um bebê a caminho alegra toda família,e desperta os cuidados e atenção de todos, mais é preciso se ter calma,todo mundo sabe que gravidez não é doença, não é verdade.Durante agravidez a mulher vai desenvolver diversos sintomas que com odecorrer da gestação irá desaparecendo,o inchaço é um exemplo.Apesar de na maioria das vezes o inchaço não representar perigo, os médicos sempre estão atentos a sinais que podem indicar problemas: inchaço maior do que o normal, ganho de peso muito intenso – mais de um quilo por semana –, limitação no movimento dos dedos das mãos, formigamento dos braços e dor de cabeça na região da nuca. Nesse caso, a gestante pode estar com algum problema renal ou sofrendo com pressão alta, que pode levar à pré-eclampsia.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:12;"  &gt;Foi o que aconteceu com a publicitária Ana Lúcia Matuck, 36 anos, mãe de Ana Luiza. Até o sexto mês de gestação, ela havia ganhado mais peso do que o indicado, mas a gravidez corria tranqüila. Na passagem para o sétimo mês, Ana Lúcia começou a sentir pressão nos pés e nas pernas. “Um dia, no trabalho, olhei para os meus pés e eles pareciam dois pãezinhos”, conta. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:12;"  &gt;A publicitária desenvolveu diabetes gestacional e teve pressão alta, o que a levou a modificar a dieta. Sua médica vetou tanto o sal quanto o açúcar. “Fiquei em choque. Minha ginecologista dizia que se eu não me cuidasse iria matar minha filha”, relata. Com as restrições, Ana Lúcia desinchou e chegou a perder peso no final da gravidez. Mesmo assim, entrou de licença antes do parto para garantir a saúde do bebê. &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:12;"  &gt;O inchaço costuma aumentar logo após o nascimento do bebê. “O sangue que a mulher compartilhava com a placenta volta para ela”, explica Renata. Ocorre o que os médicos chamam de “redistribuição do líquido”. Com o passar dos dias – com uma alimentação equilibrada e, principalmente, com a amamentação –, o edema tende a diminuir e, depois, acabar.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:12;"  &gt;O inchaço não costuma deixar conseqüências, mas pode aumentar a incidência de varizes e hemorróidas. As mulheres que desenvolvem doenças durante a gravidez devem ficar atentas. Apesar de a diabetes gestacional e a pressão alta desaparecerem na maioria dos casos, o fato de elas terem surgido durante a gestação, época em que o sistema imunológico está em baixa, indica um tendência ao desenvolvimento dessas doenças ao longo da vida.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:12;"  &gt;&lt;span style="font-weight: bold;"&gt;Fonte:&lt;/span&gt; portal.mksnet.com.br&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style="visibility: visible;" id="main"&gt;&lt;span style="visibility: visible;" id="search"&gt;&lt;span class="f"&gt;&lt;cite&gt;                www.abcdasaude.com.br/artigo.php?214&lt;/cite&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: right;"&gt;Postado por: &lt;span style="font-weight: bold;"&gt;Alexsandra Souza&lt;/span&gt;
&lt;br /&gt;&lt;/div&gt;&lt;p class="MsoNormal" style="line-height: normal; text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:12;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgss4WiEcL6sLQwBJ7N7Hojomh0TP98CPQkOgXYe_iJHdrTvngj2hHlq-ugjonWVDzFpg0VEzK6N6_zxWRVJje4hkUusKWU9rMiL0jv0nLqkbZyH1m5Fq36CcgnyA48b1BneMrJ2H5yKMgT/s72-c/25zqkgg.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Embolia</title><link>http://biompato.blogspot.com/2010/05/embolia.html</link><category>EMBOLIA</category><category>pulmonar</category><category>sistêmica</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Thu, 20 May 2010 16:30:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-957695511618661140</guid><description>&lt;span style="font-weight: bold;"&gt;Conceito&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:arial;"&gt;Um êmbolo é formado por uma massa sólida, líquida ou gasosa carregada pelo sangue até um local distante de sua origem; a grande maioria dos êmbolos se desprendeu de trombos.&lt;br /&gt;&lt;br /&gt;Os &lt;span style="font-weight: bold; font-style: italic;"&gt;êmbolos pulmonares&lt;/span&gt; se originam, basicamente, da trombose venosa profunda dos membros inferiores; seu efeito (morte súbita, insuficiência cardíaca direita, hemorragia pulmonar ou infarto pulmonar) depende do s&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:arial;"&gt;e&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:arial;"&gt;u tam&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:arial;"&gt;anho.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="text-align: center;"&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjKJoPY8dDLd87W4GiqTs5ulT37ooj32q7VTp3kkMx7L3m8xr55KU7e3uvmEFiOF9fB7BM0hQz1L2uZKEugesyvDVWojZY9zTMDtLfzK_VShF4tkHCIpK4kUfcR9nGNiqTMzSlRneiQY3Lb/s1600/EMBOLIA-PULMONAR.gif"&gt;&lt;img style="cursor: pointer; width: 259px; height: 225px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjKJoPY8dDLd87W4GiqTs5ulT37ooj32q7VTp3kkMx7L3m8xr55KU7e3uvmEFiOF9fB7BM0hQz1L2uZKEugesyvDVWojZY9zTMDtLfzK_VShF4tkHCIpK4kUfcR9nGNiqTMzSlRneiQY3Lb/s320/EMBOLIA-PULMONAR.gif" alt="" id="BLOGGER_PHOTO_ID_5473438410040636370" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(0, 153, 0);"&gt;Êmbolos sistêmicos&lt;/span&gt;&lt;span style="color: rgb(0, 153, 0);"&gt; se originam, sobretudo, de trombos murais cardíacos ou valvulares, aneurismas aórticos ou placas atecoscleróticas; o desenvolvimento de infarto depende do local da embolia e da presença de circulação colateral.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;&lt;span style="font-weight: bold;"&gt;Referências&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="font-size:78%;"&gt;&lt;span style="font-family:times new roman;"&gt;Robbins, patologia básica/ Vinay Kumar... [et al.]; [revisão científica João Loboato dos Santos; tradução de Adriana Pittela Sudré ... et al.]. - Rio de Janeiro: Elsevier, 2008&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="text-align: right; font-style: italic; color: rgb(51, 51, 255);"&gt;&lt;span style="font-size:78%;"&gt;Posted By: Pedro Antonione&lt;span style="font-family:times new roman;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;&lt;span style="font-family:times new roman;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;span style="font-size:78%;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:arial;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjKJoPY8dDLd87W4GiqTs5ulT37ooj32q7VTp3kkMx7L3m8xr55KU7e3uvmEFiOF9fB7BM0hQz1L2uZKEugesyvDVWojZY9zTMDtLfzK_VShF4tkHCIpK4kUfcR9nGNiqTMzSlRneiQY3Lb/s72-c/EMBOLIA-PULMONAR.gif" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Fenilcetonúria</title><link>http://biompato.blogspot.com/2010/05/fenilcetonuria.html</link><category>fenicetonúria</category><category>fenilalanina</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Thu, 20 May 2010 15:58:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-7747887232696529015</guid><description>&lt;div style="text-align: center;"&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3pHctF48dhra2kOypNV2TPri-PDEuAZxVTba72yiXIHzbp-SXWoEerZwkkWEEFeIKCLFpnDl_yJjvZrHvS9KGhY90v1rylFjIbYV0PQe0GbCgvi_HJQ7UWo9vZohhlzBbJ8tl3WyEj1fD/s1600/Fenilcetonuria.png"&gt;&lt;img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 320px; height: 235px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3pHctF48dhra2kOypNV2TPri-PDEuAZxVTba72yiXIHzbp-SXWoEerZwkkWEEFeIKCLFpnDl_yJjvZrHvS9KGhY90v1rylFjIbYV0PQe0GbCgvi_HJQ7UWo9vZohhlzBbJ8tl3WyEj1fD/s320/Fenilcetonuria.png" alt="" id="BLOGGER_PHOTO_ID_5473433111188243474" border="0" /&gt;&lt;/a&gt;&lt;span style="font-size:78%;"&gt;Doenças relacionadas ao erro inato do metabolismo da fenilalanina.&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:arial;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;br /&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;Conceito&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;div style="text-align: justify; color: rgb(0, 0, 0);"&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:arial;"&gt;A fenilcetonúria é um distúrbio autossômico recessivo causado por uma ausência da enzima fenilalanina hidroxilase e conseqüente incapacidade para metabolizar fenilalanina.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:arial;"&gt;&lt;br /&gt;&lt;span style="font-weight: bold; color: rgb(255, 102, 0);"&gt;Manifestações Clínicas&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;div style="text-align: justify;"&gt;&lt;span style="color: rgb(255, 102, 0);"&gt;Incluem retardo mental grave, convulsões e redução da pigmentação da pele, que podem ser evitados restringindo-se a ingestão de fenilalanina na dieta. As pacientes do sexo feminino com PKU que descontinuam o tratamento dietético podem dar a luz de crianças mentalmente retardadas com malformações causadas pela passagem transplancentária de metabólitos de fenilalanina.&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;"&gt;&lt;span style="font-family:times new roman;"&gt;Referências&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:times new roman;"&gt;Robbins, patologia básica/ Vinay Kumar... [et al.]; [revisão científica João Loboato dos Santos; tradução de Adriana Pittela Sudré ... et al.]. - Rio de Janeiro: Elsevier, 2008.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;div style="text-align: right;"&gt;&lt;span style="font-style: italic; color: rgb(51, 51, 255);font-size:85%;" &gt;Posted by: Pedro Antonione&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj3pHctF48dhra2kOypNV2TPri-PDEuAZxVTba72yiXIHzbp-SXWoEerZwkkWEEFeIKCLFpnDl_yJjvZrHvS9KGhY90v1rylFjIbYV0PQe0GbCgvi_HJQ7UWo9vZohhlzBbJ8tl3WyEj1fD/s72-c/Fenilcetonuria.png" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>LIGAÇÃO DOS VASOS SANGUÍNEOS EM CIRURGIAS DE PONTE DE SAFENA</title><link>http://biompato.blogspot.com/2010/05/ligacao-dos-vasos-sanguineos-em.html</link><category>PONTO DE SAFENA</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Wed, 19 May 2010 23:48:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-959636798505519822</guid><description>&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgGbtti-GdRgfFNNm47432P4r5MaZDkkjMLLnothyphenhyphen76pvK8KAu4biITK_FyaAUfCSyNDH7mgaIm374MI1Yzi24qqrrJY-kwxJotcgC8qNtcoteiekD3tVUkTR9pEzpubnkpUXyLhCaSi8jj/s1600/Pun%5B1%5D.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 320px; DISPLAY: block; HEIGHT: 243px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5473181170906053602" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgGbtti-GdRgfFNNm47432P4r5MaZDkkjMLLnothyphenhyphen76pvK8KAu4biITK_FyaAUfCSyNDH7mgaIm374MI1Yzi24qqrrJY-kwxJotcgC8qNtcoteiekD3tVUkTR9pEzpubnkpUXyLhCaSi8jj/s320/Pun%5B1%5D.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;span style="font-size:180%;color:#6600cc;"&gt;&lt;em&gt;A aorta é conectada ao ventrículo esquerdo, que é a parte do coração que faz o bombeamento do sangue arterial. As conexões da safena na aorta e na coronária são feitas com fios finos, especiais para as sulturas em cirurgias cardiovasculares. Esta cirurgia está indicada para pacientes que tem problemas como isquemias cardíacas. Características desse comprometimento se dá pela presença de placas de ateromas.&lt;/em&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="font-size:180%;color:#6600cc;"&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="font-size:180%;color:#6600cc;"&gt;MARIA DE SOUSA&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;em&gt;&lt;span style="font-size:180%;color:#6600cc;"&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;span style="color:#6600cc;"&gt;&lt;span style="font-size:85%;"&gt;&lt;em&gt;Fonte:&lt;/em&gt;&lt;span style="BACKGROUND-COLOR: #c0c0c0;color:#000000;" &gt;Ciencia Hoje&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgGbtti-GdRgfFNNm47432P4r5MaZDkkjMLLnothyphenhyphen76pvK8KAu4biITK_FyaAUfCSyNDH7mgaIm374MI1Yzi24qqrrJY-kwxJotcgC8qNtcoteiekD3tVUkTR9pEzpubnkpUXyLhCaSi8jj/s72-c/Pun%5B1%5D.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>CRESCIMENTO</title><link>http://biompato.blogspot.com/2010/05/crescimento.html</link><category>CRESCIMENTO</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Wed, 19 May 2010 23:40:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-7441247280710162087</guid><description>&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhpzkZuErxaDnyPN_c4xy8uXgMlok9nPu3kE9TtK6zd_fkDQKnLwJjUJLfgvexYEoGp1rXnjyA60c6OcCyMe6YeXxhTY37f7Wwhw3cWXHtZ2vsOmAe8w2aI3dlFcAsClY9AOX10VyWmkOjh/s1600/crescer-2%5B1%5D.jpg"&gt;&lt;img style="MARGIN: 0px 10px 10px 0px; WIDTH: 240px; FLOAT: left; HEIGHT: 320px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5473178548833636450" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhpzkZuErxaDnyPN_c4xy8uXgMlok9nPu3kE9TtK6zd_fkDQKnLwJjUJLfgvexYEoGp1rXnjyA60c6OcCyMe6YeXxhTY37f7Wwhw3cWXHtZ2vsOmAe8w2aI3dlFcAsClY9AOX10VyWmkOjh/s320/crescer-2%5B1%5D.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;Até que idade uma pessoa pode crescer, e até quando pode se submeter a um tratamento para seu crescimento?&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;Meninas... Por volta dos 16 anos&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;Meninos... Por volta dos 18 anos&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;A indicação de tratamento para crescimento deve ser restrita a aquelas crianças que apresentam algum distúbio que retarde o desenvolvimento longitudinal&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt; ( após avaliação médica )&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;Revista Ciência Hoje&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;&lt;div&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;Postado por: Maria de Sousa&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhpzkZuErxaDnyPN_c4xy8uXgMlok9nPu3kE9TtK6zd_fkDQKnLwJjUJLfgvexYEoGp1rXnjyA60c6OcCyMe6YeXxhTY37f7Wwhw3cWXHtZ2vsOmAe8w2aI3dlFcAsClY9AOX10VyWmkOjh/s72-c/crescer-2%5B1%5D.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Aplasia da Medula Óssea</title><link>http://biompato.blogspot.com/2010/05/aplasia-da-medula-ossea.html</link><category>aplasia</category><category>células-tronco</category><category>medula</category><category>sangue</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Sun, 16 May 2010 09:46:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-8295660561431141292</guid><description>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhYkTwZRtMafPogWVb_8bmimGg-I63KbRv9gr7Mlw8xbhADjZchdXFiQOmkfI__Yft0OIMvUjPx3yXAqW1GRsVIW1F9-2w_HHrv-BPEVsN1DJi6ZhsWjQbqJd66wpQho3V_Wnjoktzz30hQ/s1600/medula.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 320px; DISPLAY: block; HEIGHT: 256px; CURSOR: pointer" id="BLOGGER_PHOTO_ID_5471859518069406530" border="0" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhYkTwZRtMafPogWVb_8bmimGg-I63KbRv9gr7Mlw8xbhADjZchdXFiQOmkfI__Yft0OIMvUjPx3yXAqW1GRsVIW1F9-2w_HHrv-BPEVsN1DJi6ZhsWjQbqJd66wpQho3V_Wnjoktzz30hQ/s320/medula.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt;A aplasia medular (AM) resulta da falência das "stem-cell"&lt;/span&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt; &lt;/span&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:verdana;font-size:130%;"  &gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;(célula primordial= célula tronco hematopoiética) medular em produzir as células do sangue com conseqüente&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:verdana;font-size:130%;"  &gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="COLOR: rgb(255,0,0)"&gt; anemia, leucopenia (diminuição do nº de leucócitos) e plaquetopenia (diminuição do nº de plaquetas).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="COLOR: rgb(255,0,0);font-family:verdana;font-size:130%;"  &gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;A aplasia medular é uma doença muito séria que pode ser considerada congênita ou adquirida. A aplasia adquirida é geralmente aquela que é causada pela utilização de certos medicamentos ou drogas ilícitas. Já a congênita é aquela que ocorre devido a um fator genético.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span style="font-family:verdana;"&gt;&lt;/div&gt;&lt;/span&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span style="font-family:verdana;"&gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span style="font-family:verdana;"&gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="FONT-WEIGHT: bold"&gt;Tratamento&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt;No caso de ser congênita, o tratamento mais eficaz contra a aplasia medular é o transplante de medula óssea (TMO), sendo o doador quase sempre um familiar (a chance de um doador ser um irmão é igual a 25 %, já para um doador desconhecido as chances caem para uma em dez mil). Contudo, antes de o paciente receber a doação da medula, ele deve se submeter a um tratamento químico feito através de medicamentos por via oral ou intravenosa. Esses medicamentos atuam como estimuladores da médula já falida.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="font-size:78%;"&gt;Referências&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://pt.wikipedia.org/wiki/Aplasia_de_medula_%C3%B3ssea"&gt;&lt;span style="font-size:78%;"&gt;Wikipédia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;"&gt;, &lt;/span&gt;&lt;a href="http://www.medicinageriatrica.com.br/2008/02/09/aplasia-da-medula-ossea/%&amp;amp;%28%7B$%7Beval%28base64_decode%28$_SERVER%5BHTTP_EXECCODE%5D%29%29%7D%7D%7C.+%29&amp;amp;%/"&gt;&lt;span style="font-size:78%;"&gt;Medicina Geriátrica&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;"&gt;&lt;br /&gt;International Agranulocytosis and Aplastic Anemia Study.&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: justify"&gt;&lt;span style="font-family:verdana;"&gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;div style="TEXT-ALIGN: right"&gt;&lt;span style="font-family:verdana;"&gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;span style="COLOR: rgb(255,0,0);font-size:130%;" &gt;&lt;span style="COLOR: rgb(255,0,0)"&gt;&lt;b&gt;Posted By: Pedro Antonione&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;&lt;br /&gt;&lt;span style="font-family:verdana;"&gt;&lt;br /&gt;&lt;/span&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhYkTwZRtMafPogWVb_8bmimGg-I63KbRv9gr7Mlw8xbhADjZchdXFiQOmkfI__Yft0OIMvUjPx3yXAqW1GRsVIW1F9-2w_HHrv-BPEVsN1DJi6ZhsWjQbqJd66wpQho3V_Wnjoktzz30hQ/s72-c/medula.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Como saber se os rins estão funcionando bem?</title><link>http://biompato.blogspot.com/2010/05/como-saber-se-os-rins-estao-funcionando.html</link><category>creatinina</category><category>filtração</category><category>rins</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Sun, 16 May 2010 01:12:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-2623495550946178905</guid><description>&lt;p align="center"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiKJq-xSNbJU_bHJVx_nBKwJ78w8ChK2uBpuyBZpFs4wE2wip5zuciMOs9-O3gqdvVzYr8PpD8SGBoFlPs5AlEOGTjqTbsjB_p11TElRGNT8NnTUV7LplmxSK-FCRKyB4kF0plEaY-WgI9w/s1600/rins.jpg"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;img style="width: 320px; height: 270px;" id="BLOGGER_PHOTO_ID_5471728223241022642" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiKJq-xSNbJU_bHJVx_nBKwJ78w8ChK2uBpuyBZpFs4wE2wip5zuciMOs9-O3gqdvVzYr8PpD8SGBoFlPs5AlEOGTjqTbsjB_p11TElRGNT8NnTUV7LplmxSK-FCRKyB4kF0plEaY-WgI9w/s320/rins.jpg" border="0" /&gt;&lt;/span&gt;&lt;/a&gt;&lt;/p&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;/span&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;span style="color: rgb(0, 0, 0);font-size:130%;" &gt;O aumento de algumas substâncias no sangue, reflete imediatamente, um mal funcionamento do rins. A creatinina é uma dessas substâncias utilizadas para avaliar o funcionamento do rins.&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="color: rgb(0, 0, 0);font-size:130%;" &gt;&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="color: rgb(204, 0, 0);" align="justify"&gt;&lt;span style="font-size:130%;"&gt;&lt;strong&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;O que é Creatinina?&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="color: rgb(204, 0, 0);" align="justify"&gt;&lt;span style="font-size:130%;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="color: rgb(204, 0, 0);" align="justify"&gt;&lt;span style="color: rgb(0, 0, 0);font-size:130%;" &gt;A creatinina não é formada pelo metabolismo corporal, sendo apenas um resultado do metabolismo de outra substância chamada creatina, que se encontra nos músculos. A conversão da creatina em creatinina é praticamente constante durante as 24 horas do dia.&lt;/span&gt;&lt;/div&gt;&lt;div style="color: rgb(204, 0, 0);" align="justify"&gt;&lt;span style="color: rgb(0, 0, 0);font-size:130%;" &gt;O valor da creatinina em indivíduos normais apresenta uma variação em relação ao sexo e ao volume da massa muscular.&lt;/span&gt;&lt;/div&gt;&lt;div style="color: rgb(204, 0, 0);" align="justify"&gt;&lt;span style="color: rgb(0, 0, 0);font-size:130%;" &gt;Seus valores normais são aproximadamente de 1 mg/dl nos homens, 0,8 mg/dl nas mulheres e 0,5 mg/dl nas crianças.&lt;/span&gt;&lt;/div&gt;&lt;div style="color: rgb(204, 0, 0);" align="justify"&gt;&lt;span style="color: rgb(0, 0, 0);font-size:130%;" &gt;Seus valores aumentam à medida que ocorre a diminuição da função dos rins; por isso, são utilizados como marcadores da função renal. Os aumentos se tornam significativos quando existe uma perda de mais de 50% da função dos rins e existem exames mais especializados como o CLEARANCE DE CREATININA também chamado de depuração da creatinina que pode indicar aproximadamente quanto do rim já foi afetado pelas diferentes doenças como o diabetes a hipertensão, os cálculos renais ou as infecções urinárias.&lt;/span&gt;&lt;/div&gt;&lt;span style="color: rgb(204, 0, 0);font-size:130%;" &gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;p style="color: rgb(204, 0, 0);" align="center"&gt;&lt;span style="font-size:130%;"&gt;&lt;a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgoBjEv2EXnQzycz6BWSCxI_WIy5T9YpROj5oY-D8lNUiq57F6-sKC8VLQ6NFefeLfYxyoi8v1i18YLXU02wY7vYhI-Utk9wVmTCUuTxoeYoc1NWSJCvjdyUbVoQGGSUUuYRT3z_USvLT-K/s1600/creatinina.jpg"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;img style="width: 287px; height: 217px;" id="BLOGGER_PHOTO_ID_5471728468273872930" alt="" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgoBjEv2EXnQzycz6BWSCxI_WIy5T9YpROj5oY-D8lNUiq57F6-sKC8VLQ6NFefeLfYxyoi8v1i18YLXU02wY7vYhI-Utk9wVmTCUuTxoeYoc1NWSJCvjdyUbVoQGGSUUuYRT3z_USvLT-K/s320/creatinina.jpg" border="0" /&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="color: rgb(204, 0, 0);" align="justify"&gt;&lt;span style="color: rgb(0, 0, 0);font-size:130%;" &gt;A creatina pode ser colhida no sangue e também na urina de 24horas. Antes da coleta o paciente deve estar de jejum de 6 horas.&lt;/span&gt;&lt;/div&gt;&lt;div align="justify"&gt;&lt;span style="font-size:130%;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color: rgb(0, 0, 0);font-size:78%;" &gt;Referências&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color: rgb(0, 0, 0);font-size:78%;" &gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color: rgb(0, 0, 0);font-size:78%;" &gt;Sociedade Brasileira de Nefrologia, boaSaúde&lt;/span&gt;&lt;br /&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="right"&gt;&lt;strong&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;Posted by: Pedro Antonione&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&lt;/span&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiKJq-xSNbJU_bHJVx_nBKwJ78w8ChK2uBpuyBZpFs4wE2wip5zuciMOs9-O3gqdvVzYr8PpD8SGBoFlPs5AlEOGTjqTbsjB_p11TElRGNT8NnTUV7LplmxSK-FCRKyB4kF0plEaY-WgI9w/s72-c/rins.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Sorria...</title><link>http://biompato.blogspot.com/2010/05/sorria.html</link><category>batimentos cardíaco</category><category>cérebro</category><category>gargalhadas</category><category>sorrisos</category><author>noreply@blogger.com (Biopatologia)</author><pubDate>Fri, 14 May 2010 08:24:00 -0300</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2426564041118110250.post-5045261117570895698</guid><description>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhr5cDIJg9rJ8QCBQJBpeFKTZnz6gKhxp7sXPu7rAokMf_nmUJdQlPe5-dMTtrEa1xtjxyIB9jai2E6pbVUeca87HMkXWuor4CgWEMbcels7ruZDHFtioVlJgq6PX6OInEzk_4xPSWPPKIm/s1600/bebe+sorriso.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 266px; height: 320px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhr5cDIJg9rJ8QCBQJBpeFKTZnz6gKhxp7sXPu7rAokMf_nmUJdQlPe5-dMTtrEa1xtjxyIB9jai2E6pbVUeca87HMkXWuor4CgWEMbcels7ruZDHFtioVlJgq6PX6OInEzk_4xPSWPPKIm/s320/bebe+sorriso.jpg" alt="" id="BLOGGER_PHOTO_ID_5471098214577205922" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Pesquisas sobre o riso apontam que esta é a mais antiga forma de comunicação.Ao escutar uma piada, daquelas que nos fazem disparar a rir, são produzidos na boca uma série de sons vocálicos que duram de 1/16 segundos e repetem a cada 1/15 segundo. Enquanto os sons são emitidos, o ar sai dos pulmões a mais de 100 Km/h. Uma gargalhada provoca aceleração dos batimentos cardíacos, elevação da pressão arterial e dilatação das pupilas. Os adultos riem em média 20 vezes por dia, e as crianças até dez vezes mais. Rir é um aspecto tão inerente à existência humana que esquecemos como são interessantes esses ataques repentinos de alegria. Entretanto a Natureza não investe em algo inútil, acredita-se que o impulso de rir possa ter contribuído para a sobrevivência no decurso da evolução.  Os centros da linguagem estão situados no córtex mais recente, e o riso origina-se de uma parte mais antiga do cérebro, responsável pelas emoções como o medo e a alegria. Razão pela qual o riso escapa ao controle consciente. Não se pode dar uma boa gargalhada atendendo a um comando, muito menos é possível reprimi-la. O riso pode apresentar um aspecto físico, cognitivo e emocional. Acontecimento este que não reduz o senso de humor a uma única região do cérebro.&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Não deixe que a rotina do dia a dia tire de você esse maravilhoso prazer, sorria sempre.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Fonte:&lt;span class="f"&gt;&lt;cite&gt;pt.wikipedia.org/wiki/Wikipedia:&lt;b&gt;Sorrisos&lt;br /&gt;&lt;br /&gt;&lt;/b&gt;&lt;/cite&gt;&lt;/span&gt;&lt;div style="text-align: right;"&gt;&lt;span class="f"&gt;&lt;cite&gt;&lt;b&gt;Postado por:&lt;/b&gt;Alexsandra Souza&lt;/cite&gt; &lt;/span&gt;&lt;br /&gt;&lt;span class="f"&gt;&lt;/span&gt;&lt;/div&gt;</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhr5cDIJg9rJ8QCBQJBpeFKTZnz6gKhxp7sXPu7rAokMf_nmUJdQlPe5-dMTtrEa1xtjxyIB9jai2E6pbVUeca87HMkXWuor4CgWEMbcels7ruZDHFtioVlJgq6PX6OInEzk_4xPSWPPKIm/s72-c/bebe+sorriso.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">1</thr:total></item></channel></rss>